[
  {
    "prevalence_id": "4",
    "orpha_code": "61",
    "disease_name": "Alpha-mannosidosis",
    "source": "European Medicines Agency 2005[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14",
    "orpha_code": "118",
    "disease_name": "Beta-mannosidosis",
    "source": "14685153[PMID]_10480370[PMID]_20490927[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8334",
    "orpha_code": "166078",
    "disease_name": "Von Willebrand disease type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "35",
    "orpha_code": "213",
    "disease_name": "Cystinosis",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10555",
    "orpha_code": "213",
    "disease_name": "Cystinosis",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "45",
    "orpha_code": "365",
    "disease_name": "Glycogen storage disease due to acid maltase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14791",
    "orpha_code": "365",
    "disease_name": "Glycogen storage disease due to acid maltase deficiency",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13351",
    "orpha_code": "447",
    "disease_name": "Paroxysmal nocturnal hemoglobinuria",
    "source": "European Medicines Agency 2016[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "77",
    "orpha_code": "535",
    "disease_name": "Rare cutaneous lupus erythematosus",
    "source": "European Medicines Agency 2007[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "67",
    "orpha_code": "487",
    "disease_name": "Krabbe disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "69",
    "orpha_code": "487",
    "disease_name": "Krabbe disease",
    "source": "20301416[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8347",
    "orpha_code": "166260",
    "disease_name": "Dentinogenesis imperfecta type 2",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "80",
    "orpha_code": "583",
    "disease_name": "Mucopolysaccharidosis type 6",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "97",
    "orpha_code": "583",
    "disease_name": "Mucopolysaccharidosis type 6",
    "source": "European Medicines Agency 2001[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "100",
    "orpha_code": "576",
    "disease_name": "Mucolipidosis type II",
    "source": "10480370[PMID]_14685153[PMID]_ 25274184[PMID]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "101",
    "orpha_code": "576",
    "disease_name": "Mucolipidosis type II",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "99",
    "orpha_code": "812",
    "disease_name": "Sialidosis type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10874",
    "orpha_code": "812",
    "disease_name": "Sialidosis type 1",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "16554",
    "orpha_code": "577",
    "disease_name": "Mucolipidosis type III",
    "source": "10480370[PMID]_ 14685153[PMID]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17124",
    "orpha_code": "577",
    "disease_name": "Mucolipidosis type III",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8357",
    "orpha_code": "166291",
    "disease_name": "Dirofilariasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "110",
    "orpha_code": "2912",
    "disease_name": "Poliomyelitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11957",
    "orpha_code": "2912",
    "disease_name": "Poliomyelitis",
    "source": "European Centre for Disease prevention and Control 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "129",
    "orpha_code": "796",
    "disease_name": "Sandhoff disease",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "130",
    "orpha_code": "796",
    "disease_name": "Sandhoff disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "139",
    "orpha_code": "461",
    "disease_name": "Recessive X-linked ichthyosis",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "140",
    "orpha_code": "461",
    "disease_name": "Recessive X-linked ichthyosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "136",
    "orpha_code": "584",
    "disease_name": "Mucopolysaccharidosis type 7",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "144",
    "orpha_code": "881",
    "disease_name": "Turner syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 1985-2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "166",
    "orpha_code": "881",
    "disease_name": "Turner syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "167",
    "orpha_code": "95",
    "disease_name": "Friedreich ataxia",
    "source": "20301458[PMID]_23859338[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "232",
    "orpha_code": "848",
    "disease_name": "Beta-thalassemia",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "233",
    "orpha_code": "848",
    "disease_name": "Beta-thalassemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "228",
    "orpha_code": "846",
    "disease_name": "Alpha-thalassemia",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17460",
    "orpha_code": "846",
    "disease_name": "Alpha-thalassemia",
    "source": "25390741[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "16663",
    "orpha_code": "586",
    "disease_name": "Cystic fibrosis",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16664",
    "orpha_code": "586",
    "disease_name": "Cystic fibrosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "235",
    "orpha_code": "262",
    "disease_name": "Duchenne and Becker muscular dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "236",
    "orpha_code": "261",
    "disease_name": "Emery-Dreifuss muscular dystrophy",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11974",
    "orpha_code": "550",
    "disease_name": "MELAS",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "239",
    "orpha_code": "269",
    "disease_name": "Facioscapulohumeral dystrophy",
    "source": "19320656[PMID]_22217918[PMID]_19767415[PMID]_[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "237",
    "orpha_code": "480",
    "disease_name": "Kearns-Sayre syndrome",
    "source": "[EXPERT]_17886296[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12229",
    "orpha_code": "551",
    "disease_name": "MERRF",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "246",
    "orpha_code": "597",
    "disease_name": "Central core disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "247",
    "orpha_code": "607",
    "disease_name": "Nemaline myopathy",
    "source": "ORPHANET_15221447[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14770",
    "orpha_code": "684",
    "disease_name": "Paramyotonia congenita of Von Eulenburg",
    "source": "ORPHANET_23516313[PMID]_29606556[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "255",
    "orpha_code": "273",
    "disease_name": "Steinert myotonic dystrophy",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8301",
    "orpha_code": "163934",
    "disease_name": "Atopic keratoconjunctivitis",
    "source": "European Medicines Agency 2009[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "251",
    "orpha_code": "614",
    "disease_name": "Thomsen and Becker disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "300",
    "orpha_code": "324",
    "disease_name": "Fabry disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "281",
    "orpha_code": "778",
    "disease_name": "Rett syndrome",
    "source": "12378695[PMID]_21878110[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "282",
    "orpha_code": "778",
    "disease_name": "Rett syndrome",
    "source": "European Medicines Agency 2019[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "270",
    "orpha_code": "72",
    "disease_name": "Angelman syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "271",
    "orpha_code": "72",
    "disease_name": "Angelman syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2009[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "305",
    "orpha_code": "1941",
    "disease_name": "Juvenile absence epilepsy",
    "source": "8275976[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "306",
    "orpha_code": "1941",
    "disease_name": "Juvenile absence epilepsy",
    "source": "ORPHANET_Dr Gabrielle Rudolf[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "304",
    "orpha_code": "892",
    "disease_name": "Von Hippel-Lindau disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14619",
    "orpha_code": "731",
    "disease_name": "Autosomal recessive polycystic kidney disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "14792",
    "orpha_code": "138",
    "disease_name": "CHARGE syndrome",
    "source": "European Medicines Agency 2019[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "373",
    "orpha_code": "558",
    "disease_name": "Marfan syndrome",
    "source": "16325700[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "375",
    "orpha_code": "558",
    "disease_name": "Marfan syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "325",
    "orpha_code": "803",
    "disease_name": "Amyotrophic lateral sclerosis",
    "source": "19710046[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "326",
    "orpha_code": "803",
    "disease_name": "Amyotrophic lateral sclerosis",
    "source": "19192301[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "311",
    "orpha_code": "100",
    "disease_name": "Ataxia-telangiectasia",
    "source": "ORPHANET_19339254[PMID]_23609960[PMID]_19440741[PMID]_1512613[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "313",
    "orpha_code": "733",
    "disease_name": "Familial adenomatous polyposis",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "421",
    "orpha_code": "399",
    "disease_name": "Huntington disease",
    "source": "European Medicines Agency 2019[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "418",
    "orpha_code": "501",
    "disease_name": "Lafora disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "395",
    "orpha_code": "870",
    "disease_name": "Down syndrome",
    "source": "33130823[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": ">1 / 1000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5000.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "396",
    "orpha_code": "870",
    "disease_name": "Down syndrome",
    "source": "33130823[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "383",
    "orpha_code": "512",
    "disease_name": "Metachromatic leukodystrophy",
    "source": "21496291[PMID]_[EXPERT]_European Medicines Agency 2010[INST]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "384",
    "orpha_code": "512",
    "disease_name": "Metachromatic leukodystrophy",
    "source": "21496291[PMID]_[EXPERT]_European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "480",
    "orpha_code": "567",
    "disease_name": "22q11.2 deletion syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14799",
    "orpha_code": "567",
    "disease_name": "22q11.2 deletion syndrome",
    "source": "European Medicines Agency 2019[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "472",
    "orpha_code": "232",
    "disease_name": "Sickle cell anemia",
    "source": "European Medicines Agency 2019[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14566",
    "orpha_code": "536",
    "disease_name": "Systemic lupus erythematosus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "460",
    "orpha_code": "534",
    "disease_name": "Oculocerebrorenal syndrome of Lowe",
    "source": "16722554[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "453",
    "orpha_code": "790",
    "disease_name": "Retinoblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "454",
    "orpha_code": "790",
    "disease_name": "Retinoblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10557",
    "orpha_code": "790",
    "disease_name": "Retinoblastoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "452",
    "orpha_code": "652",
    "disease_name": "Multiple endocrine neoplasia type 1",
    "source": "20301710[PMID]_17014705[PMID]_ [EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "447",
    "orpha_code": "908",
    "disease_name": "Fragile X syndrome",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12495",
    "orpha_code": "908",
    "disease_name": "Fragile X syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "530",
    "orpha_code": "3099",
    "disease_name": "Rheumatic fever",
    "source": "21386976[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "541",
    "orpha_code": "739",
    "disease_name": "Prader-Willi syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "542",
    "orpha_code": "739",
    "disease_name": "Prader-Willi syndrome",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "553",
    "orpha_code": "47",
    "disease_name": "X-linked agammaglobulinemia",
    "source": "19419768[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "484",
    "orpha_code": "580",
    "disease_name": "Mucopolysaccharidosis type 2",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "501",
    "orpha_code": "580",
    "disease_name": "Mucopolysaccharidosis type 2",
    "source": "European Medicines Agency 2018 [INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "502",
    "orpha_code": "579",
    "disease_name": "Mucopolysaccharidosis type 1",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "519",
    "orpha_code": "579",
    "disease_name": "Mucopolysaccharidosis type 1",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "521",
    "orpha_code": "905",
    "disease_name": "Wilson disease",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10714",
    "orpha_code": "792",
    "disease_name": "X-linked retinoschisis",
    "source": "17172462[PMID]_1918822[PMID]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "612",
    "orpha_code": "827",
    "disease_name": "Stargardt disease",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "572",
    "orpha_code": "906",
    "disease_name": "Wiskott-Aldrich syndrome",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "584",
    "orpha_code": "280",
    "disease_name": "Wolf-Hirschhorn syndrome",
    "source": "11480768[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "585",
    "orpha_code": "280",
    "disease_name": "Wolf-Hirschhorn syndrome",
    "source": "11480768[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "588",
    "orpha_code": "15",
    "disease_name": "Achondroplasia",
    "source": "32803853[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "599",
    "orpha_code": "96",
    "disease_name": "Ataxia with vitamin E deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "602",
    "orpha_code": "101",
    "disease_name": "Dentatorubral pallidoluysian atrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "605",
    "orpha_code": "783",
    "disease_name": "Rubinstein-Taybi syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "606",
    "orpha_code": "783",
    "disease_name": "Rubinstein-Taybi syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "643",
    "orpha_code": "631",
    "disease_name": "Non-acquired isolated growth hormone deficiency",
    "source": "22851490[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "642",
    "orpha_code": "276",
    "disease_name": "T-B+ severe combined immunodeficiency due to gamma chain deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17511",
    "orpha_code": "481",
    "disease_name": "Kennedy disease",
    "source": "9724012[PMID]_11949733[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "629",
    "orpha_code": "664",
    "disease_name": "Ornithine transcarbamylase deficiency",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "647",
    "orpha_code": "394",
    "disease_name": "Homocystinuria due to cystathionine beta-synthase deficiency",
    "source": "European Medicines Agency 2001[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "644",
    "orpha_code": "508",
    "disease_name": "Donohue syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "645",
    "orpha_code": "508",
    "disease_name": "Donohue syndrome",
    "source": "9128805[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "625",
    "orpha_code": "104",
    "disease_name": "Leber hereditary optic neuropathy",
    "source": "21928272[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "692",
    "orpha_code": "636",
    "disease_name": "Neurofibromatosis type 1",
    "source": "10991696[PMID]_20082463[PMID]_2511318[PMID]_6807042[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "659",
    "orpha_code": "379",
    "disease_name": "Chronic granulomatous disease",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "660",
    "orpha_code": "379",
    "disease_name": "Chronic granulomatous disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "687",
    "orpha_code": "644",
    "disease_name": "NARP syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "688",
    "orpha_code": "637",
    "disease_name": "Full NF2-related schwannomatosis",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "684",
    "orpha_code": "181",
    "disease_name": "X-linked hypohidrotic ectodermal dysplasia",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "685",
    "orpha_code": "181",
    "disease_name": "X-linked hypohidrotic ectodermal dysplasia",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10716",
    "orpha_code": "337",
    "disease_name": "Fibrodysplasia ossificans progressiva",
    "source": "ORPHANET_22796417[PMID]_28666455[PMID]_7069743[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "744",
    "orpha_code": "377",
    "disease_name": "Gorlin syndrome",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14793",
    "orpha_code": "214",
    "disease_name": "Cystinuria",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "715",
    "orpha_code": "510",
    "disease_name": "Lesch-Nyhan syndrome",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "724",
    "orpha_code": "510",
    "disease_name": "Lesch-Nyhan syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "704",
    "orpha_code": "640",
    "disease_name": "Hereditary neuropathy with liability to pressure palsies",
    "source": "[EXPERT]_24646194[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "708",
    "orpha_code": "60",
    "disease_name": "Alpha-1-antitrypsin deficiency",
    "source": "European Medicines Agency 2016[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "764",
    "orpha_code": "857",
    "disease_name": "Townes-Brocks syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "765",
    "orpha_code": "894",
    "disease_name": "Waardenburg syndrome type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "759",
    "orpha_code": "682",
    "disease_name": "Hyperkalemic periodic paralysis",
    "source": "20301669[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "752",
    "orpha_code": "628",
    "disease_name": "Diastrophic dysplasia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "753",
    "orpha_code": "628",
    "disease_name": "Diastrophic dysplasia",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "756",
    "orpha_code": "673",
    "disease_name": "Malaria",
    "source": "European Medicines Agency2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11955",
    "orpha_code": "673",
    "disease_name": "Malaria",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "758",
    "orpha_code": "681",
    "disease_name": "Hypokalemic periodic paralysis",
    "source": "20301512[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "778",
    "orpha_code": "774",
    "disease_name": "Hereditary hemorrhagic telangiectasia",
    "source": "30111344[PMID]_[EXPERT]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "776",
    "orpha_code": "794",
    "disease_name": "Saethre-Chotzen syndrome",
    "source": "15923834[PMID]_8988166[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "777",
    "orpha_code": "794",
    "disease_name": "Saethre-Chotzen syndrome",
    "source": "15923834[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "775",
    "orpha_code": "710",
    "disease_name": "Pfeiffer syndrome",
    "source": "16740155[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "773",
    "orpha_code": "2869",
    "disease_name": "Peutz-Jeghers syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "813",
    "orpha_code": "53",
    "disease_name": "Albers-Schnberg osteopetrosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "803",
    "orpha_code": "52",
    "disease_name": "Alagille syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "797",
    "orpha_code": "195",
    "disease_name": "Cat-eye syndrome",
    "source": "17001329[PMID]_Dr Catherine TURLEAU[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11625",
    "orpha_code": "195",
    "disease_name": "Cat-eye syndrome",
    "source": "ORPHANET_Dr Catherine TURLEAU[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "794",
    "orpha_code": "207",
    "disease_name": "Crouzon syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "795",
    "orpha_code": "207",
    "disease_name": "Crouzon syndrome",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "791",
    "orpha_code": "205",
    "disease_name": "Crigler-Najjar syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "792",
    "orpha_code": "205",
    "disease_name": "Crigler-Najjar syndrome",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "790",
    "orpha_code": "192",
    "disease_name": "Coffin-Lowry syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "848",
    "orpha_code": "2442",
    "disease_name": "X-linked lymphoproliferative disease",
    "source": "20301580[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8444",
    "orpha_code": "169802",
    "disease_name": "Severe hemophilia A",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "856",
    "orpha_code": "562",
    "disease_name": "McCune-Albright syndrome",
    "source": "18489744[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "852",
    "orpha_code": "565",
    "disease_name": "Menkes disease",
    "source": "1999344[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "851",
    "orpha_code": "2443",
    "disease_name": "Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "866",
    "orpha_code": "474",
    "disease_name": "Jeune syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10936",
    "orpha_code": "564",
    "disease_name": "Meckel syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 1990-2011[REG]_25182137[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "872",
    "orpha_code": "289",
    "disease_name": "Ellis Van Creveld syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "869",
    "orpha_code": "258",
    "disease_name": "Laminin subunit alpha 2-related congenital muscular dystrophy",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "816",
    "orpha_code": "1247",
    "disease_name": "Schistosomiasis",
    "source": "18445419[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "818",
    "orpha_code": "112",
    "disease_name": "Bartter syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "815",
    "orpha_code": "1646",
    "disease_name": "Chromosome Y microdeletion syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "841",
    "orpha_code": "99",
    "disease_name": "Autosomal dominant cerebellar ataxia",
    "source": "23609960[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "822",
    "orpha_code": "116",
    "disease_name": "Beckwith-Wiedemann syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "827",
    "orpha_code": "116",
    "disease_name": "Beckwith-Wiedemann syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "828",
    "orpha_code": "87",
    "disease_name": "Apert syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "844",
    "orpha_code": "313",
    "disease_name": "Lamellar ichthyosis",
    "source": "9887377[PMID]_22000705[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8443",
    "orpha_code": "169799",
    "disease_name": "Mild hemophilia B",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8442",
    "orpha_code": "169796",
    "disease_name": "Moderate hemophilia B",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8441",
    "orpha_code": "169793",
    "disease_name": "Severe hemophilia B",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8445",
    "orpha_code": "171430",
    "disease_name": "Severe congenital nemaline myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8446",
    "orpha_code": "171433",
    "disease_name": "Intermediate nemaline myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8447",
    "orpha_code": "171436",
    "disease_name": "Typical nemaline myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8448",
    "orpha_code": "171439",
    "disease_name": "Childhood-onset nemaline myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8449",
    "orpha_code": "171442",
    "disease_name": "Adult-onset nemaline myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "880",
    "orpha_code": "861",
    "disease_name": "Treacher-Collins syndrome",
    "source": "6024864[PMID]_14198411[PMID]_21131976[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "881",
    "orpha_code": "861",
    "disease_name": "Treacher-Collins syndrome",
    "source": "6024864[PMID]_14198411[PMID]_ [EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "890",
    "orpha_code": "199",
    "disease_name": "Cornelia de Lange syndrome",
    "source": "18074387[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "894",
    "orpha_code": "2162",
    "disease_name": "Holoprosencephaly",
    "source": "20104599[PMID]_[EXPERT]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "902",
    "orpha_code": "930",
    "disease_name": "Idiopathic achalasia",
    "source": "23871090[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "965",
    "orpha_code": "3380",
    "disease_name": "Trisomy 18 syndrome",
    "source": "22713804[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2009[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "966",
    "orpha_code": "3380",
    "disease_name": "Trisomy 18 syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2009[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8424",
    "orpha_code": "168999",
    "disease_name": "Malignant melanoma of the mucosa",
    "source": "22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8425",
    "orpha_code": "168999",
    "disease_name": "Malignant melanoma of the mucosa",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "8426",
    "orpha_code": "168999",
    "disease_name": "Malignant melanoma of the mucosa",
    "source": "22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "943",
    "orpha_code": "3378",
    "disease_name": "Trisomy 13 syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2009[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "963",
    "orpha_code": "3378",
    "disease_name": "Trisomy 13 syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8429",
    "orpha_code": "169085",
    "disease_name": "Susceptibility to respiratory infections associated with CD8alpha chain mutation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8415",
    "orpha_code": "168811",
    "disease_name": "Malignant peritoneal mesothelioma",
    "source": "European Medicines Agency 2016[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10718",
    "orpha_code": "218",
    "disease_name": "Darier disease",
    "source": "1390140[PMID]_11841374[PMID]_16001099[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8411",
    "orpha_code": "168782",
    "disease_name": "Childhood disintegrative disorder",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13693",
    "orpha_code": "168966",
    "disease_name": "Composite lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13705",
    "orpha_code": "168960",
    "disease_name": "Refractory anemia with excess blasts in transformation",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "941",
    "orpha_code": "8",
    "disease_name": "47,XYY syndrome",
    "source": "22893477[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "942",
    "orpha_code": "8",
    "disease_name": "47,XYY syndrome",
    "source": "22893477[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8421",
    "orpha_code": "168956",
    "disease_name": "Hypereosinophilic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "13712",
    "orpha_code": "168956",
    "disease_name": "Hypereosinophilic syndrome",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "938",
    "orpha_code": "1598",
    "disease_name": "Monosomy 18p syndrome",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12557",
    "orpha_code": "1598",
    "disease_name": "Monosomy 18p syndrome",
    "source": "18284672[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1009",
    "orpha_code": "626",
    "disease_name": "Large/giant congenital melanocytic nevus",
    "source": "21139903[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1015",
    "orpha_code": "773",
    "disease_name": "Refsum disease",
    "source": "20301527[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "994",
    "orpha_code": "370",
    "disease_name": "Glycogen storage disease due to phosphorylase kinase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "995",
    "orpha_code": "370",
    "disease_name": "Glycogen storage disease due to phosphorylase kinase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "996",
    "orpha_code": "385",
    "disease_name": "Neurodegeneration with brain iron accumulation",
    "source": "[EXPERT]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "991",
    "orpha_code": "352",
    "disease_name": "Galactosemia",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "990",
    "orpha_code": "352",
    "disease_name": "Galactosemia",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11995",
    "orpha_code": "596",
    "disease_name": "X-linked centronuclear myopathy",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1008",
    "orpha_code": "610",
    "disease_name": "Bethlem muscular dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "998",
    "orpha_code": "464",
    "disease_name": "Incontinentia pigmenti",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1000",
    "orpha_code": "3307",
    "disease_name": "Tetrasomy 18p syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1062",
    "orpha_code": "56",
    "disease_name": "Alkaptonuria",
    "source": "European Medicines Agency 2003[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1027",
    "orpha_code": "915",
    "disease_name": "Aarskog-Scott syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12497",
    "orpha_code": "2614",
    "disease_name": "Nail-patella syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1029",
    "orpha_code": "33",
    "disease_name": "Isovaleric acidemia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1020",
    "orpha_code": "819",
    "disease_name": "Smith-Magenis syndrome",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1103",
    "orpha_code": "1452",
    "disease_name": "Cleidocranial dysplasia",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1085",
    "orpha_code": "124",
    "disease_name": "Diamond-Blackfan anemia",
    "source": "20824457[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8394",
    "orpha_code": "168572",
    "disease_name": "Native American myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1077",
    "orpha_code": "90",
    "disease_name": "Argininemia",
    "source": "European Medicines Agency 2016[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1080",
    "orpha_code": "1143",
    "disease_name": "Neurogenic arthrogryposis multiplex congenita",
    "source": "23050160[PMID]_22005589[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10559",
    "orpha_code": "1143",
    "disease_name": "Neurogenic arthrogryposis multiplex congenita",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "1147",
    "orpha_code": "1775",
    "disease_name": "Dyskeratosis congenita",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1143",
    "orpha_code": "1764",
    "disease_name": "Familial dysautonomia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1139",
    "orpha_code": "235",
    "disease_name": "Dubowitz syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13707",
    "orpha_code": "167714",
    "disease_name": "Unclassified acute myeloid leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11989",
    "orpha_code": "765",
    "disease_name": "Pyruvate dehydrogenase deficiency",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1126",
    "orpha_code": "23",
    "disease_name": "Argininosuccinic aciduria",
    "source": "European Medicines Agency 2019[INST]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1118",
    "orpha_code": "217",
    "disease_name": "Isolated Dandy-Walker malformation",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1119",
    "orpha_code": "217",
    "disease_name": "Isolated Dandy-Walker malformation",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1246",
    "orpha_code": "2248",
    "disease_name": "Hypoplastic left heart syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1218",
    "orpha_code": "2140",
    "disease_name": "Congenital diaphragmatic hernia",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11302",
    "orpha_code": "2185",
    "disease_name": "Congenital hydrocephalus",
    "source": "19410489[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1153",
    "orpha_code": "1880",
    "disease_name": "Ebstein malformation of the tricuspid valve",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1154",
    "orpha_code": "1880",
    "disease_name": "Ebstein malformation of the tricuspid valve",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1151",
    "orpha_code": "255",
    "disease_name": "Dopa-responsive dystonia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1177",
    "orpha_code": "1915",
    "disease_name": "Fetal alcohol syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1341",
    "orpha_code": "660",
    "disease_name": "Omphalocele",
    "source": "[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1342",
    "orpha_code": "660",
    "disease_name": "Omphalocele",
    "source": "[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1334",
    "orpha_code": "635",
    "disease_name": "Neuroblastoma",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1335",
    "orpha_code": "635",
    "disease_name": "Neuroblastoma",
    "source": "16919772[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12500",
    "orpha_code": "2635",
    "disease_name": "Metatropic dysplasia",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1325",
    "orpha_code": "2655",
    "disease_name": "Thanatophoric dysplasia",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1326",
    "orpha_code": "2655",
    "disease_name": "Thanatophoric dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1320",
    "orpha_code": "606",
    "disease_name": "Proximal myotonic myopathy",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1392",
    "orpha_code": "705",
    "disease_name": "Pendred syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1390",
    "orpha_code": "884",
    "disease_name": "Pallister-Killian syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1411",
    "orpha_code": "744",
    "disease_name": "Proteus syndrome",
    "source": "21793738[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1412",
    "orpha_code": "744",
    "disease_name": "Proteus syndrome",
    "source": "21793738[PMID]_[EXPERT]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1407",
    "orpha_code": "2901",
    "disease_name": "Neuralgic amyotrophy",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1404",
    "orpha_code": "718",
    "disease_name": "Isolated Pierre Robin sequence",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1405",
    "orpha_code": "718",
    "disease_name": "Isolated Pierre Robin sequence",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1436",
    "orpha_code": "290",
    "disease_name": "Congenital rubella syndrome",
    "source": "22178098[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1437",
    "orpha_code": "290",
    "disease_name": "Congenital rubella syndrome",
    "source": "22178098[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1423",
    "orpha_code": "763",
    "disease_name": "Pycnodysostosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1268",
    "orpha_code": "469",
    "disease_name": "Hereditary fructose intolerance",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13654",
    "orpha_code": "180226",
    "disease_name": "Embryonal carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13657",
    "orpha_code": "180229",
    "disease_name": "Polyembryoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1286",
    "orpha_code": "2346",
    "disease_name": "Angioosteohypertrophic syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1290",
    "orpha_code": "506",
    "disease_name": "Leigh syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11977",
    "orpha_code": "506",
    "disease_name": "Leigh syndrome",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13653",
    "orpha_code": "180234",
    "disease_name": "Mixed germ cell tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8543",
    "orpha_code": "180242",
    "disease_name": "Malignant tumor of fallopian tubes",
    "source": "European Medicines Agency 2009[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13622",
    "orpha_code": "180275",
    "disease_name": "Paget disease of the nipple",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1298",
    "orpha_code": "2444",
    "disease_name": "Congenital pulmonary airway malformation",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17133",
    "orpha_code": "2444",
    "disease_name": "Congenital pulmonary airway malformation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "1508",
    "orpha_code": "716",
    "disease_name": "Phenylketonuria",
    "source": "34082800[PMID]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1509",
    "orpha_code": "716",
    "disease_name": "Phenylketonuria",
    "source": "32668217[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1545",
    "orpha_code": "1020",
    "disease_name": "Early-onset autosomal dominant Alzheimer disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1543",
    "orpha_code": "63",
    "disease_name": "Alport syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "1537",
    "orpha_code": "54",
    "disease_name": "X-linked recessive ocular albinism",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1538",
    "orpha_code": "54",
    "disease_name": "X-linked recessive ocular albinism",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1556",
    "orpha_code": "154",
    "disease_name": "Familial isolated dilated cardiomyopathy",
    "source": "16839424[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1557",
    "orpha_code": "154",
    "disease_name": "Familial isolated dilated cardiomyopathy",
    "source": "16839424[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1550",
    "orpha_code": "84",
    "disease_name": "Fanconi anemia",
    "source": "20824457[PMID]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1552",
    "orpha_code": "84",
    "disease_name": "Fanconi anemia",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1547",
    "orpha_code": "70",
    "disease_name": "Proximal spinal muscular atrophy",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1548",
    "orpha_code": "70",
    "disease_name": "Proximal spinal muscular atrophy",
    "source": "23107878[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10562",
    "orpha_code": "70",
    "disease_name": "Proximal spinal muscular atrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1572",
    "orpha_code": "191",
    "disease_name": "Cockayne syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1573",
    "orpha_code": "191",
    "disease_name": "Cockayne syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1561",
    "orpha_code": "166",
    "disease_name": "Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy",
    "source": "21820100[PMID]_20301532[PMID]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10560",
    "orpha_code": "799",
    "disease_name": "Schizencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "8541",
    "orpha_code": "178566",
    "disease_name": "Mycosis fungoides and variants",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1444",
    "orpha_code": "813",
    "disease_name": "Silver-Russell syndrome",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1447",
    "orpha_code": "813",
    "disease_name": "Silver-Russell syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1448",
    "orpha_code": "813",
    "disease_name": "Silver-Russell syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1451",
    "orpha_code": "3169",
    "disease_name": "Sirenomelia",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1452",
    "orpha_code": "3169",
    "disease_name": "Sirenomelia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1469",
    "orpha_code": "816",
    "disease_name": "Sjgren-Larsson syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1472",
    "orpha_code": "821",
    "disease_name": "Sotos syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1473",
    "orpha_code": "821",
    "disease_name": "Sotos syndrome",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1476",
    "orpha_code": "3205",
    "disease_name": "Sturge-Weber syndrome",
    "source": "24275166[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10561",
    "orpha_code": "3205",
    "disease_name": "Sturge-Weber syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1477",
    "orpha_code": "3320",
    "disease_name": "Thrombocytopenia-absent radius syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1492",
    "orpha_code": "3346",
    "disease_name": "Tracheal agenesis",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1493",
    "orpha_code": "3346",
    "disease_name": "Tracheal agenesis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1479",
    "orpha_code": "858",
    "disease_name": "Congenital toxoplasmosis",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1497",
    "orpha_code": "887",
    "disease_name": "VACTERL/VATER association",
    "source": "21846383[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8527",
    "orpha_code": "178478",
    "disease_name": "Infant botulism",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8528",
    "orpha_code": "178478",
    "disease_name": "Infant botulism",
    "source": "[EXPERT]_Center for Diseases Control and Prevention[INST]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8525",
    "orpha_code": "178475",
    "disease_name": "Wound botulism",
    "source": "[EXPERT]_Center for Diseases Control and Prevention[INST]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1825",
    "orpha_code": "117",
    "disease_name": "Behet disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1793",
    "orpha_code": "732",
    "disease_name": "Polymyositis",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1794",
    "orpha_code": "732",
    "disease_name": "Polymyositis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1781",
    "orpha_code": "611",
    "disease_name": "Inclusion body myositis",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1671",
    "orpha_code": "581",
    "disease_name": "Mucopolysaccharidosis type 3",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1688",
    "orpha_code": "581",
    "disease_name": "Mucopolysaccharidosis type 3",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1695",
    "orpha_code": "685",
    "disease_name": "Hereditary spastic paraplegia",
    "source": "ORPHANET_2043954[PMID]_19339254[PMID]_19039240[PMID]_23609960[PMID]_1512613[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8494",
    "orpha_code": "178029",
    "disease_name": "Arginine vasopressin deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1648",
    "orpha_code": "418",
    "disease_name": "Congenital adrenal hyperplasia",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1649",
    "orpha_code": "418",
    "disease_name": "Congenital adrenal hyperplasia",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1650",
    "orpha_code": "418",
    "disease_name": "Congenital adrenal hyperplasia",
    "source": "15964450[PMID]_15554889[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14795",
    "orpha_code": "216",
    "disease_name": "Neuronal ceroid lipofuscinosis",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1604",
    "orpha_code": "355",
    "disease_name": "Gaucher disease",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1605",
    "orpha_code": "355",
    "disease_name": "Gaucher disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1622",
    "orpha_code": "388",
    "disease_name": "Hirschsprung disease",
    "source": "25066220[PMID]_Eurocat",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17134",
    "orpha_code": "388",
    "disease_name": "Hirschsprung disease",
    "source": "25066220[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1620",
    "orpha_code": "448",
    "disease_name": "Hemophilia",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1621",
    "orpha_code": "448",
    "disease_name": "Hemophilia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1600",
    "orpha_code": "354",
    "disease_name": "GM1 gangliosidosis",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8502",
    "orpha_code": "178320",
    "disease_name": "Acute lung injury",
    "source": "15659944[PMID]_15166842[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8503",
    "orpha_code": "178320",
    "disease_name": "Acute lung injury",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10563",
    "orpha_code": "760",
    "disease_name": "Purine nucleoside phosphorylase deficiency",
    "source": "ORPHANET_30885031[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1741",
    "orpha_code": "270",
    "disease_name": "Oculopharyngeal muscular dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1744",
    "orpha_code": "244",
    "disease_name": "Primary ciliary dyskinesia",
    "source": "23871404[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1745",
    "orpha_code": "589",
    "disease_name": "Myasthenia gravis",
    "source": "20130418[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1746",
    "orpha_code": "589",
    "disease_name": "Myasthenia gravis",
    "source": "17986328[PMID]_[EXPERT]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1734",
    "orpha_code": "3440",
    "disease_name": "Waardenburg syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1737",
    "orpha_code": "3440",
    "disease_name": "Waardenburg syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1699",
    "orpha_code": "702",
    "disease_name": "Pelizaeus-Merzbacher disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1706",
    "orpha_code": "791",
    "disease_name": "Retinitis pigmentosa",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1971",
    "orpha_code": "375",
    "disease_name": "Anti-glomerular basement membrane disease",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14794",
    "orpha_code": "375",
    "disease_name": "Anti-glomerular basement membrane disease",
    "source": "European Medicines Agency 2018 [INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1961",
    "orpha_code": "183",
    "disease_name": "Eosinophilic granulomatosis with polyangiitis",
    "source": "ORPHANET_25805746[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10849",
    "orpha_code": "183",
    "disease_name": "Eosinophilic granulomatosis with polyangiitis",
    "source": "ORPHANET_19797309[PMID]_18565978[PMID]_11156552[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1979",
    "orpha_code": "509",
    "disease_name": "Leptospirosis",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1980",
    "orpha_code": "509",
    "disease_name": "Leptospirosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8487",
    "orpha_code": "171901",
    "disease_name": "Primary cutaneous T-cell lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]_21493798[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8488",
    "orpha_code": "171901",
    "disease_name": "Primary cutaneous T-cell lymphoma",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13695",
    "orpha_code": "171915",
    "disease_name": "B-cell non-Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13694",
    "orpha_code": "171918",
    "disease_name": "T-cell non-Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2016",
    "orpha_code": "442",
    "disease_name": "Congenital hypothyroidism",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2017",
    "orpha_code": "442",
    "disease_name": "Congenital hypothyroidism",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11962",
    "orpha_code": "810",
    "disease_name": "Shigellosis",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1985",
    "orpha_code": "727",
    "disease_name": "Microscopic polyangiitis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2001",
    "orpha_code": "900",
    "disease_name": "Granulomatosis with polyangiitis",
    "source": "16859601[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2002",
    "orpha_code": "900",
    "disease_name": "Granulomatosis with polyangiitis",
    "source": "16859601[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2000",
    "orpha_code": "863",
    "disease_name": "Trichinellosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11964",
    "orpha_code": "863",
    "disease_name": "Trichinellosis",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8463",
    "orpha_code": "171700",
    "disease_name": "Diffuse panbronchiolitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1827",
    "orpha_code": "3467",
    "disease_name": "Hereditary xanthinuria",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8460",
    "orpha_code": "171673",
    "disease_name": "Limbal stem cell deficiency",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10564",
    "orpha_code": "511",
    "disease_name": "Maple syrup urine disease",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1909",
    "orpha_code": "2368",
    "disease_name": "Gastroschisis",
    "source": "EUROCAT European surveillance of congenital anomalies 2010-2016[REG]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1928",
    "orpha_code": "2368",
    "disease_name": "Gastroschisis",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10565",
    "orpha_code": "795",
    "disease_name": "Rare form of salmonellosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1935",
    "orpha_code": "797",
    "disease_name": "Sarcoidosis",
    "source": "European Medicines Agency 2007[INST]_DOI:10.1016/B978-0-323-54429-0.00001-X[OTHER]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1845",
    "orpha_code": "92",
    "disease_name": "Juvenile idiopathic arthritis",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1850",
    "orpha_code": "1201",
    "disease_name": "Small bowel atresia",
    "source": "229330959[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17137",
    "orpha_code": "1201",
    "disease_name": "Small bowel atresia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "1883",
    "orpha_code": "1199",
    "disease_name": "Esophageal atresia",
    "source": "22247246[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1884",
    "orpha_code": "1199",
    "disease_name": "Esophageal atresia",
    "source": "22247246[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11946",
    "orpha_code": "1304",
    "disease_name": "Brucellosis",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1904",
    "orpha_code": "173",
    "disease_name": "Cholera",
    "source": "World Health Organization 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11948",
    "orpha_code": "173",
    "disease_name": "Cholera",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2200",
    "orpha_code": "3303",
    "disease_name": "Tetralogy of Fallot",
    "source": "[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17139",
    "orpha_code": "3303",
    "disease_name": "Tetralogy of Fallot",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "13737",
    "orpha_code": "730",
    "disease_name": "Autosomal dominant polycystic kidney disease",
    "source": "27325254[PMID]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2223",
    "orpha_code": "486",
    "disease_name": "Autosomal dominant severe congenital neutropenia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2178",
    "orpha_code": "1209",
    "disease_name": "Tricuspid atresia",
    "source": "31270117[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2179",
    "orpha_code": "1209",
    "disease_name": "Tricuspid atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2194",
    "orpha_code": "1478",
    "disease_name": "Interatrial communication",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2238",
    "orpha_code": "1959",
    "disease_name": "Evans syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2233",
    "orpha_code": "284",
    "disease_name": "Alveolar echinococcosis",
    "source": "23301116[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10566",
    "orpha_code": "284",
    "disease_name": "Alveolar echinococcosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2231",
    "orpha_code": "1177",
    "disease_name": "Early-onset cerebellar ataxia with retained tendon reflexes",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2225",
    "orpha_code": "828",
    "disease_name": "Stickler syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2226",
    "orpha_code": "828",
    "disease_name": "Stickler syndrome",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2142",
    "orpha_code": "3287",
    "disease_name": "Takayasu arteritis",
    "source": "ORPHANET_27159262[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2143",
    "orpha_code": "3287",
    "disease_name": "Takayasu arteritis",
    "source": "ORPHANET_27159262[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2172",
    "orpha_code": "3463",
    "disease_name": "Wolfram syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2175",
    "orpha_code": "549",
    "disease_name": "Legionnaires disease",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2158",
    "orpha_code": "704",
    "disease_name": "Pemphigus vulgaris",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2118",
    "orpha_code": "3452",
    "disease_name": "Whipple disease",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8608",
    "orpha_code": "199285",
    "disease_name": "Hereditary hypercarotenemia and vitamin A deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2109",
    "orpha_code": "3002",
    "disease_name": "Immune thrombocytopenia",
    "source": "European Medicines Agency 2007[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2112",
    "orpha_code": "3002",
    "disease_name": "Immune thrombocytopenia",
    "source": "ISBN:70703868[OTHER]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8610",
    "orpha_code": "199302",
    "disease_name": "Isolated cleft lip",
    "source": "Pr Marie-Paule VAZQUEZ_Dr Eva GALLIANI[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8611",
    "orpha_code": "199306",
    "disease_name": "Cleft lip/palate",
    "source": "Pr Marie-Paule VAZQUEZ_Dr Eva GALLIANI[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2128",
    "orpha_code": "926",
    "disease_name": "Acatalasemia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2123",
    "orpha_code": "1531",
    "disease_name": "Craniosynostosis",
    "source": "EUROCAT European surveillance of congenital anomalies 2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8601",
    "orpha_code": "189427",
    "disease_name": "Cushing syndrome due to bilateral macronodular adrenocortical disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2088",
    "orpha_code": "976",
    "disease_name": "Adenine phosphoribosyltransferase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11927",
    "orpha_code": "415",
    "disease_name": "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
    "source": "European Medicines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "17431",
    "orpha_code": "13",
    "disease_name": "6-pyruvoyl-tetrahydropterin synthase deficiency",
    "source": "30853107[PMID]_32456656[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2094",
    "orpha_code": "171",
    "disease_name": "Primary sclerosing cholangitis",
    "source": "21351115[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2095",
    "orpha_code": "171",
    "disease_name": "Primary sclerosing cholangitis",
    "source": "ORPHANET_9489916[PMID]_18433916[PMID]_23775876[PMID]_7890895[PMID]_20683956[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8605",
    "orpha_code": "199247",
    "disease_name": "Corticosteroid-binding globulin deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2091",
    "orpha_code": "2134",
    "disease_name": "Atypical hemolytic uremic syndrome",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2443",
    "orpha_code": "3006",
    "disease_name": "Pyridoxine-dependent-developmental and epileptic encephalopathy",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2450",
    "orpha_code": "780",
    "disease_name": "Rhabdomyosarcoma",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2455",
    "orpha_code": "2382",
    "disease_name": "Lennox-Gastaut syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2456",
    "orpha_code": "2382",
    "disease_name": "Lennox-Gastaut syndrome",
    "source": "[EXPERT]_European Medicines Agency 2004[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2452",
    "orpha_code": "2806",
    "disease_name": "Subacute sclerosing leukoencephalitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10723",
    "orpha_code": "2467",
    "disease_name": "Systemic mastocytosis",
    "source": "24761987[PMID]_8645532[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10725",
    "orpha_code": "2467",
    "disease_name": "Systemic mastocytosis",
    "source": "23219169[PMID]_24761987[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2472",
    "orpha_code": "1934",
    "disease_name": "Early infantile developmental and epileptic encephalopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2465",
    "orpha_code": "845",
    "disease_name": "Tay-Sachs disease",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17140",
    "orpha_code": "845",
    "disease_name": "Tay-Sachs disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11963",
    "orpha_code": "3299",
    "disease_name": "Tetanus",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "16287",
    "orpha_code": "3299",
    "disease_name": "Tetanus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2341",
    "orpha_code": "770",
    "disease_name": "Rabies",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11959",
    "orpha_code": "770",
    "disease_name": "Rabies",
    "source": "European Centre for Disease prevention and Control 2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2343",
    "orpha_code": "3386",
    "disease_name": "American trypanosomiasis",
    "source": "21944556[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2354",
    "orpha_code": "267",
    "disease_name": "Calpain-3-related limb-girdle muscular dystrophy R1",
    "source": "European Medicines Agency 2006[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2358",
    "orpha_code": "1329",
    "disease_name": "Complete atrioventricular septal defect",
    "source": "16722604[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2372",
    "orpha_code": "582",
    "disease_name": "Mucopolysaccharidosis type 4",
    "source": "28595941[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17512",
    "orpha_code": "582",
    "disease_name": "Mucopolysaccharidosis type 4",
    "source": "18681890[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2373",
    "orpha_code": "2137",
    "disease_name": "Autoimmune hepatitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2376",
    "orpha_code": "2137",
    "disease_name": "Autoimmune hepatitis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2388",
    "orpha_code": "186",
    "disease_name": "Primary biliary cholangitis",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2391",
    "orpha_code": "186",
    "disease_name": "Primary biliary cholangitis",
    "source": "17873609[PMID]_22562114[PMID]_24387641[PMID]_17918011[PMID]_22961000[PMID]_10421645[PMID]_9279616[PMID]_20347176[PMID]_24502439[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2420",
    "orpha_code": "397",
    "disease_name": "Giant cell arteritis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2421",
    "orpha_code": "2932",
    "disease_name": "Chronic inflammatory demyelinating polyneuropathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2432",
    "orpha_code": "1656",
    "disease_name": "Dermatitis herpetiformis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2270",
    "orpha_code": "3198",
    "disease_name": "Stiff person spectrum disorder",
    "source": "21921002[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2268",
    "orpha_code": "2929",
    "disease_name": "Juvenile polyposis syndrome",
    "source": "20301642[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2286",
    "orpha_code": "131",
    "disease_name": "Budd-Chiari syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2278",
    "orpha_code": "646",
    "disease_name": "Niemann-Pick disease type C",
    "source": "20525256[PMID]_European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2273",
    "orpha_code": "654",
    "disease_name": "Nephroblastoma",
    "source": "22357215[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2274",
    "orpha_code": "654",
    "disease_name": "Nephroblastoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2275",
    "orpha_code": "654",
    "disease_name": "Nephroblastoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2277",
    "orpha_code": "654",
    "disease_name": "Nephroblastoma",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11956",
    "orpha_code": "1489",
    "disease_name": "Whooping cough",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2293",
    "orpha_code": "2764",
    "disease_name": "Osteochondritis dissecans",
    "source": "16958015[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12502",
    "orpha_code": "3389",
    "disease_name": "Tuberculosis",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12540",
    "orpha_code": "3389",
    "disease_name": "Tuberculosis",
    "source": "World Health Organization 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11951",
    "orpha_code": "1679",
    "disease_name": "Diphtheria",
    "source": "European Centre for Disease prevention and Control 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2296",
    "orpha_code": "1267",
    "disease_name": "Botulism",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2242",
    "orpha_code": "2103",
    "disease_name": "Guillain-Barr syndrome",
    "source": "[EXPERT]_European Medicines Agency 2007[INST]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2244",
    "orpha_code": "2103",
    "disease_name": "Guillain-Barr syndrome",
    "source": "22694000[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8585",
    "orpha_code": "183669",
    "disease_name": "Agammaglobulinemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10567",
    "orpha_code": "2070",
    "disease_name": "Eosinophilic gastroenteritis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2249",
    "orpha_code": "2314",
    "disease_name": "Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2250",
    "orpha_code": "2314",
    "disease_name": "Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2246",
    "orpha_code": "449",
    "disease_name": "Hepatoblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11954",
    "orpha_code": "533",
    "disease_name": "Listeriosis",
    "source": "European Centre for Disease prevention and Control 2012-2016[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2263",
    "orpha_code": "683",
    "disease_name": "Progressive supranuclear palsy",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2254",
    "orpha_code": "677",
    "disease_name": "Pancreatoblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8578",
    "orpha_code": "183660",
    "disease_name": "Severe combined immunodeficiency",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12499",
    "orpha_code": "808",
    "disease_name": "Seckel syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10726",
    "orpha_code": "676",
    "disease_name": "Autosomal dominant hereditary chronic pancreatitis",
    "source": "18755888[PMID]_20502448[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2537",
    "orpha_code": "634",
    "disease_name": "Netherton syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2538",
    "orpha_code": "634",
    "disease_name": "Netherton syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2527",
    "orpha_code": "2828",
    "disease_name": "Young-onset Parkinson disease",
    "source": "ORPHANET_23083512[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2521",
    "orpha_code": "326",
    "disease_name": "Congenital factor V deficiency",
    "source": "ORPHANET_19598066[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2514",
    "orpha_code": "342",
    "disease_name": "Familial Mediterranean fever",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2516",
    "orpha_code": "180",
    "disease_name": "Choroideremia",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2506",
    "orpha_code": "327",
    "disease_name": "Congenital factor VII deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2497",
    "orpha_code": "653",
    "disease_name": "Multiple endocrine neoplasia type 2",
    "source": "ISBN:9283224167[OTHER]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2495",
    "orpha_code": "146",
    "disease_name": "Differentiated thyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11986",
    "orpha_code": "157",
    "disease_name": "Carnitine palmitoyltransferase II deficiency",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2602",
    "orpha_code": "392",
    "disease_name": "Holt-Oram syndrome",
    "source": "25344219[PMID]_EUROCAT European surveillance of congenital anomalies 1990-2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8575",
    "orpha_code": "183422",
    "disease_name": "Polymalformative genetic syndrome with increased risk of developing cancer",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2592",
    "orpha_code": "136",
    "disease_name": "Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy",
    "source": "12146805[PMID]_15834040[PMID]_22422895[PMID]_[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8571",
    "orpha_code": "182114",
    "disease_name": "Rare urogenital tumor",
    "source": "22425262[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2591",
    "orpha_code": "48",
    "disease_name": "Congenital bilateral absence of vas deferens",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8573",
    "orpha_code": "182130",
    "disease_name": "Tumor of endocrine glands",
    "source": "22361014[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8574",
    "orpha_code": "182130",
    "disease_name": "Tumor of endocrine glands",
    "source": "22361014[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2595",
    "orpha_code": "528",
    "disease_name": "Congenital generalized lipodystrophy",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8554",
    "orpha_code": "182090",
    "disease_name": "Pulmonary arterial hypertension",
    "source": "European Medicines Agency 2018[INST]_16456139[PMID]_17360728[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8567",
    "orpha_code": "182095",
    "disease_name": "Interstitial lung disease",
    "source": "24636811[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8551",
    "orpha_code": "182067",
    "disease_name": "Glial tumor",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13659",
    "orpha_code": "182067",
    "disease_name": "Glial tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2584",
    "orpha_code": "189",
    "disease_name": "Hidrotic ectodermal dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8549",
    "orpha_code": "182050",
    "disease_name": "MYH9-related syndromic thrombocytopenia",
    "source": "20301740[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2546",
    "orpha_code": "902",
    "disease_name": "Werner syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2560",
    "orpha_code": "888",
    "disease_name": "Van der Woude syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2618",
    "orpha_code": "507",
    "disease_name": "Leishmaniasis",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2621",
    "orpha_code": "233",
    "disease_name": "Duane retraction syndrome",
    "source": "ISBN:3642022014[OTHER]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16538",
    "orpha_code": "2495",
    "disease_name": "Meningioma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2614",
    "orpha_code": "569",
    "disease_name": "Familial or sporadic hemiplegic migraine",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2628",
    "orpha_code": "2014",
    "disease_name": "Cleft palate",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2629",
    "orpha_code": "2014",
    "disease_name": "Cleft palate",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2625",
    "orpha_code": "358",
    "disease_name": "Gitelman syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2626",
    "orpha_code": "2052",
    "disease_name": "Fraser syndrome",
    "source": "23532946[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2686",
    "orpha_code": "557",
    "disease_name": "Non-syndromic anorectal malformation",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2009[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2705",
    "orpha_code": "557",
    "disease_name": "Non-syndromic anorectal malformation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2706",
    "orpha_code": "111",
    "disease_name": "Barth syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2683",
    "orpha_code": "10",
    "disease_name": "48,XXYY syndrome",
    "source": "[EXPERT]_568179[PMID]_14477077[PMID]_2090319[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2711",
    "orpha_code": "1308",
    "disease_name": "C syndrome",
    "source": "[EXPERT]_17162528[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11993",
    "orpha_code": "150",
    "disease_name": "Nasopharyngeal carcinoma",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13802",
    "orpha_code": "150",
    "disease_name": "Nasopharyngeal carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2726",
    "orpha_code": "1552",
    "disease_name": "Currarino syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2727",
    "orpha_code": "1580",
    "disease_name": "Distal deletion 10p syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2760",
    "orpha_code": "3375",
    "disease_name": "Trisomy X syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2759",
    "orpha_code": "3000",
    "disease_name": "Familial peripheral male-limited precocious puberty",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2761",
    "orpha_code": "3376",
    "disease_name": "Triploidy syndrome",
    "source": "22234154[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10568",
    "orpha_code": "932",
    "disease_name": "Achondrogenesis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2788",
    "orpha_code": "37",
    "disease_name": "Acrodermatitis enteropathica",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2781",
    "orpha_code": "945",
    "disease_name": "Acalvaria",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2740",
    "orpha_code": "1762",
    "disease_name": "Proximal Xq28 duplication syndrome",
    "source": "ORPHANET_EXPERT",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2861",
    "orpha_code": "1037",
    "disease_name": "Arthrogryposis multiplex congenita",
    "source": "22005589[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10569",
    "orpha_code": "1037",
    "disease_name": "Arthrogryposis multiplex congenita",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "2825",
    "orpha_code": "990",
    "disease_name": "Agnathia-holoprosencephaly-situs inversus syndrome",
    "source": "20849990[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2830",
    "orpha_code": "994",
    "disease_name": "Fetal akinesia deformation sequence",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2831",
    "orpha_code": "994",
    "disease_name": "Fetal akinesia deformation sequence",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2828",
    "orpha_code": "51",
    "disease_name": "Aicardi-Goutires syndrome",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2822",
    "orpha_code": "983",
    "disease_name": "Testicular regression syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "8138",
    "orpha_code": "139423",
    "disease_name": "Idiopathic acute transverse myelitis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2848",
    "orpha_code": "64",
    "disease_name": "Alstrm syndrome",
    "source": "[EXPERT]_22043170[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2843",
    "orpha_code": "701",
    "disease_name": "Alopecia universalis",
    "source": "European Medicines Agency 2006[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13772",
    "orpha_code": "59",
    "disease_name": "Allan-Herndon-Dudley syndrome",
    "source": "European Medecines Agency 2017[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8053",
    "orpha_code": "137577",
    "disease_name": "Neonatal hypoxic and ischemic brain injury",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12922",
    "orpha_code": "137583",
    "disease_name": "Vulvar intraepithelial neoplasia",
    "source": "European Medicines Agency 2008[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10655",
    "orpha_code": "137605",
    "disease_name": "Legius syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12845",
    "orpha_code": "137596",
    "disease_name": "Neurotrophic keratopathy",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8089",
    "orpha_code": "137839",
    "disease_name": "Lemierre syndrome",
    "source": "20181152[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8080",
    "orpha_code": "137698",
    "disease_name": "Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk",
    "source": "European Medicines Agency 2012[INST]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13352",
    "orpha_code": "137686",
    "disease_name": "Asherman syndrome",
    "source": "European Medicines Agency 2017[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2923",
    "orpha_code": "1159",
    "disease_name": "Progressive pseudorheumatoid dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2974",
    "orpha_code": "1215",
    "disease_name": "Autosomal dominant optic atrophy plus syndrome",
    "source": "22197506[PMID]_22776096[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10657",
    "orpha_code": "138044",
    "disease_name": "Rare disease with Pierre Robin syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "8096",
    "orpha_code": "137888",
    "disease_name": "Auriculocondylar syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8104",
    "orpha_code": "137914",
    "disease_name": "Choanal atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8105",
    "orpha_code": "137914",
    "disease_name": "Choanal atresia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8121",
    "orpha_code": "137917",
    "disease_name": "Choanal atresia, unilateral",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8122",
    "orpha_code": "137917",
    "disease_name": "Choanal atresia, unilateral",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10656",
    "orpha_code": "137920",
    "disease_name": "Choanal atresia, bilateral",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "16272",
    "orpha_code": "1198",
    "disease_name": "Colonic atresia",
    "source": "ORPHANET_2342005[PMID]_16080929[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2943",
    "orpha_code": "1203",
    "disease_name": "Duodenal atresia",
    "source": "22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2944",
    "orpha_code": "1203",
    "disease_name": "Duodenal atresia",
    "source": "22933095[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8224",
    "orpha_code": "141253",
    "disease_name": "Oblique facial cleft",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8225",
    "orpha_code": "141291",
    "disease_name": "Cleft lip and alveolus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12181",
    "orpha_code": "141083",
    "disease_name": "Nasolacrimal duct cyst",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10659",
    "orpha_code": "141099",
    "disease_name": "Proboscis lateralis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3082",
    "orpha_code": "1375",
    "disease_name": "Cataract-hypertrichosis-intellectual disability syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8238",
    "orpha_code": "157826",
    "disease_name": "Congenital epulis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10660",
    "orpha_code": "157798",
    "disease_name": "Serrated polyposis syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8230",
    "orpha_code": "157215",
    "disease_name": "Hereditary hypophosphatemic rickets with hypercalciuria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8227",
    "orpha_code": "156152",
    "disease_name": "Anti-neutrophil cytoplasmic antibody-associated vasculitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3061",
    "orpha_code": "1335",
    "disease_name": "Pentalogy of Cantrell",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3062",
    "orpha_code": "1335",
    "disease_name": "Pentalogy of Cantrell",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3213",
    "orpha_code": "726",
    "disease_name": "Alpers-Huttenlocher syndrome",
    "source": "19766516_Pr Robert NAVIAUX[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3214",
    "orpha_code": "726",
    "disease_name": "Alpers-Huttenlocher syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11961",
    "orpha_code": "140896",
    "disease_name": "Severe acute respiratory syndrome",
    "source": "European Centre for Disease prevention and Control 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8197",
    "orpha_code": "140949",
    "disease_name": "Low-flow priapism",
    "source": "European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8194",
    "orpha_code": "140941",
    "disease_name": "Short stature due to primary acid-labile subunit deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10658",
    "orpha_code": "141000",
    "disease_name": "Orofaciodigital syndrome type 11",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "16833",
    "orpha_code": "140286",
    "disease_name": "Secondary hypoparathyroidism due to impaired parathormon secretion",
    "source": "29087618[PMID]_23661265[PMID]_29516129[PMID]_30375660[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16834",
    "orpha_code": "140286",
    "disease_name": "Secondary hypoparathyroidism due to impaired parathormon secretion",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3321",
    "orpha_code": "2209",
    "disease_name": "Maternal phenylketonuria syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10883",
    "orpha_code": "2209",
    "disease_name": "Maternal phenylketonuria syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3312",
    "orpha_code": "294",
    "disease_name": "Fetal cytomegalovirus syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3298",
    "orpha_code": "1896",
    "disease_name": "EEC syndrome",
    "source": "ISBN:978-0-387-21753-6[OTHER]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3299",
    "orpha_code": "1896",
    "disease_name": "EEC syndrome",
    "source": "ORPHANET_ISBN:978-0-387-21753-6[OTHER]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14550",
    "orpha_code": "1906",
    "disease_name": "Fetal valproate spectrum disorder",
    "source": "29753923[PMID]_EUROCAT European surveillance of congenital anomalies 2005-2014[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3286",
    "orpha_code": "1872",
    "disease_name": "Cone rod dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3280",
    "orpha_code": "254",
    "disease_name": "Spondylometaphyseal dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3272",
    "orpha_code": "251",
    "disease_name": "Multiple epiphyseal dysplasia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3262",
    "orpha_code": "1802",
    "disease_name": "Ghosal hematodiaphyseal dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "17480",
    "orpha_code": "1798",
    "disease_name": "Craniofacial dysostosis-diaphyseal hyperplasia syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3445",
    "orpha_code": "2130",
    "disease_name": "Non-syndromic hemimelia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10572",
    "orpha_code": "2138",
    "disease_name": "46,XX ovotesticular difference of sex development",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3450",
    "orpha_code": "2139",
    "disease_name": "Hernndez-Aguirre Negrete syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3438",
    "orpha_code": "2114",
    "disease_name": "Hip dysplasia, Beukes type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8253",
    "orpha_code": "157997",
    "disease_name": "Benign cephalic histiocytosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8252",
    "orpha_code": "157991",
    "disease_name": "Generalized eruptive histiocytosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3430",
    "orpha_code": "380",
    "disease_name": "Greig cephalopolysyndactyly syndrome",
    "source": "ORPHANET_ 25297527[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8241",
    "orpha_code": "157835",
    "disease_name": "Paroxysmal hemicrania",
    "source": "[EXPERT]_29720814[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "8244",
    "orpha_code": "157850",
    "disease_name": "Pantothenate kinase-associated neurodegeneration",
    "source": "22027213[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8245",
    "orpha_code": "157946",
    "disease_name": "Huntington disease-like 3",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10571",
    "orpha_code": "250",
    "disease_name": "Frontonasal dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12496",
    "orpha_code": "250",
    "disease_name": "Frontonasal dysplasia",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10863",
    "orpha_code": "2059",
    "disease_name": "Fryns syndrome",
    "source": "2650934[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3371",
    "orpha_code": "2019",
    "disease_name": "Femur-fibula-ulna complex",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3372",
    "orpha_code": "2019",
    "disease_name": "Femur-fibula-ulna complex",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3357",
    "orpha_code": "2004",
    "disease_name": "Laryngotracheoesophageal cleft",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3369",
    "orpha_code": "2017",
    "disease_name": "Sternal cleft",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3370",
    "orpha_code": "2017",
    "disease_name": "Sternal cleft",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10574",
    "orpha_code": "2340",
    "disease_name": "Keratosis follicularis spinulosa decalvans",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10667",
    "orpha_code": "247604",
    "disease_name": "Juvenile primary lateral sclerosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3603",
    "orpha_code": "2337",
    "disease_name": "Diffuse palmoplantar keratoderma, Bothnian type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3582",
    "orpha_code": "2322",
    "disease_name": "Kabuki syndrome",
    "source": "[EXPERT]_21882399[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9068",
    "orpha_code": "247525",
    "disease_name": "Citrullinemia type I",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9100",
    "orpha_code": "248111",
    "disease_name": "Juvenile Huntington disease",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9101",
    "orpha_code": "248111",
    "disease_name": "Juvenile Huntington disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3619",
    "orpha_code": "2369",
    "disease_name": "Limb body wall complex",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3656",
    "orpha_code": "2451",
    "disease_name": "Mucocutaneous venous malformations",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3650",
    "orpha_code": "2440",
    "disease_name": "Isolated split hand-split foot malformation",
    "source": "8766141[PMID]_EUROCAT European surveillance of congenital anomalies[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3655",
    "orpha_code": "2440",
    "disease_name": "Isolated split hand-split foot malformation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3645",
    "orpha_code": "296",
    "disease_name": "Ollier disease",
    "source": "16995932[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9063",
    "orpha_code": "247353",
    "disease_name": "Generalized pustular psoriasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9059",
    "orpha_code": "247257",
    "disease_name": "Inhalational anthrax",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3675",
    "orpha_code": "2485",
    "disease_name": "Melorheostosis",
    "source": "9040882[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9054",
    "orpha_code": "247234",
    "disease_name": "Sporadic adult-onset ataxia of unknown etiology",
    "source": "20083040[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13648",
    "orpha_code": "247203",
    "disease_name": "Collecting duct carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3671",
    "orpha_code": "2481",
    "disease_name": "Neurocutaneous melanocytosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13667",
    "orpha_code": "251630",
    "disease_name": "Anaplastic oligodendroglioma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9165",
    "orpha_code": "251636",
    "disease_name": "Ependymoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10669",
    "orpha_code": "251636",
    "disease_name": "Ependymoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "13669",
    "orpha_code": "251639",
    "disease_name": "Subependymoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9166",
    "orpha_code": "251643",
    "disease_name": "Myxopapillary ependymoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10670",
    "orpha_code": "251643",
    "disease_name": "Myxopapillary ependymoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "13665",
    "orpha_code": "251651",
    "disease_name": "Oligoastrocytic tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3482",
    "orpha_code": "2189",
    "disease_name": "Hydrolethalus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10773",
    "orpha_code": "251679",
    "disease_name": "Astroblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3487",
    "orpha_code": "312",
    "disease_name": "Autosomal dominant epidermolytic ichthyosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10573",
    "orpha_code": "2196",
    "disease_name": "Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13670",
    "orpha_code": "251852",
    "disease_name": "Embryonal tumor of neuroepithelial tissue",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13660",
    "orpha_code": "251576",
    "disease_name": "Gliosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13663",
    "orpha_code": "251582",
    "disease_name": "Gliomatosis cerebri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13661",
    "orpha_code": "251579",
    "disease_name": "Giant cell glioblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3463",
    "orpha_code": "2152",
    "disease_name": "Mowat-Wilson syndrome",
    "source": "21343952[PMID]_20301585[PMID]_ ISBN:470191414[OTHER]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13662",
    "orpha_code": "251598",
    "disease_name": "Protoplasmic astrocytoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13664",
    "orpha_code": "251607",
    "disease_name": "Pleomorphic xanthoastrocytoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13666",
    "orpha_code": "251627",
    "disease_name": "Oligodendroglioma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13671",
    "orpha_code": "251863",
    "disease_name": "Desmoplastic/nodular medulloblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13672",
    "orpha_code": "251870",
    "disease_name": "Central nervous system embryonal tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9169",
    "orpha_code": "251899",
    "disease_name": "Choroid plexus carcinoma",
    "source": "2033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9170",
    "orpha_code": "251899",
    "disease_name": "Choroid plexus carcinoma",
    "source": "2033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9171",
    "orpha_code": "251899",
    "disease_name": "Choroid plexus carcinoma",
    "source": "2033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10774",
    "orpha_code": "251909",
    "disease_name": "Pineoblastoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9102",
    "orpha_code": "250923",
    "disease_name": "Isolated aniridia",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9105",
    "orpha_code": "250923",
    "disease_name": "Isolated aniridia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10668",
    "orpha_code": "251380",
    "disease_name": "Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3575",
    "orpha_code": "2315",
    "disease_name": "Johanson-Blizzard syndrome",
    "source": "16311597[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17144",
    "orpha_code": "2315",
    "disease_name": "Johanson-Blizzard syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3565",
    "orpha_code": "2290",
    "disease_name": "Microvillus inclusion disease",
    "source": "16800870[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9172",
    "orpha_code": "252164",
    "disease_name": "Benign schwannoma",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3815",
    "orpha_code": "2750",
    "disease_name": "Orofaciodigital syndrome type 1",
    "source": "20301367[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3832",
    "orpha_code": "2770",
    "disease_name": "Nasu-Hakola disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "17479",
    "orpha_code": "2767",
    "disease_name": "Carpotarsal osteochondromatosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "16418",
    "orpha_code": "252175",
    "disease_name": "Vestibular schwannoma",
    "source": null,
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 3.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3844",
    "orpha_code": "2788",
    "disease_name": "Osteoporosis-pseudoglioma syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3837",
    "orpha_code": "667",
    "disease_name": "Autosomal recessive malignant osteopetrosis",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3838",
    "orpha_code": "667",
    "disease_name": "Autosomal recessive malignant osteopetrosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16792",
    "orpha_code": "254698",
    "disease_name": "Epithelioid trophoblastic tumor",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3857",
    "orpha_code": "675",
    "disease_name": "Annular pancreas",
    "source": "[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3700",
    "orpha_code": "2551",
    "disease_name": "Microspherophakia-metaphyseal dysplasia syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10575",
    "orpha_code": "575",
    "disease_name": "Muckle-Wells syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3727",
    "orpha_code": "2573",
    "disease_name": "Moyamoya disease",
    "source": "ISBN:9783211243381[OTHER]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3728",
    "orpha_code": "2573",
    "disease_name": "Moyamoya disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3732",
    "orpha_code": "2578",
    "disease_name": "Mayer-Rokitansky-Kster-Hauser syndrome type 2",
    "source": "19821675[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3733",
    "orpha_code": "2578",
    "disease_name": "Mayer-Rokitansky-Kster-Hauser syndrome type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10671",
    "orpha_code": "261236",
    "disease_name": "16p13.11 microdeletion syndrome",
    "source": "ORPHANET_23637818[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9235",
    "orpha_code": "261197",
    "disease_name": "Proximal 16p11.2 microdeletion syndrome",
    "source": "19306953[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9262",
    "orpha_code": "261318",
    "disease_name": "Trisomy 20p syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9332",
    "orpha_code": "263543",
    "disease_name": "Generalized peeling skin syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9316",
    "orpha_code": "263479",
    "disease_name": "Fuchs heterochromic iridocyclitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9304",
    "orpha_code": "263432",
    "disease_name": "Nevus of Ito",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9300",
    "orpha_code": "263413",
    "disease_name": "Angiosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9301",
    "orpha_code": "263413",
    "disease_name": "Angiosarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9302",
    "orpha_code": "263413",
    "disease_name": "Angiosarcoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9297",
    "orpha_code": "263352",
    "disease_name": "Postcardiotomy right ventricular failure",
    "source": "European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3999",
    "orpha_code": "3004",
    "disease_name": "Mirror polydactyly-vertebral segmentation-limbs defects syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9286",
    "orpha_code": "263310",
    "disease_name": "Thymoma type A",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9288",
    "orpha_code": "263317",
    "disease_name": "Thymoma type B",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9290",
    "orpha_code": "263324",
    "disease_name": "Thymoma type AB",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4059",
    "orpha_code": "798",
    "disease_name": "Schinzel-Giedion syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4048",
    "orpha_code": "3110",
    "disease_name": "Rombo syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10578",
    "orpha_code": "3086",
    "disease_name": "Autosomal dominant vitreoretinochoroidopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10579",
    "orpha_code": "3088",
    "disease_name": "Revesz syndrome",
    "source": "ORPHANET_1404302[PMID]_18252230[PMID]_21477109[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9360",
    "orpha_code": "268316",
    "disease_name": "Complication in hemodialysis",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9361",
    "orpha_code": "268316",
    "disease_name": "Complication in hemodialysis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10673",
    "orpha_code": "268162",
    "disease_name": "Intermediate maple syrup urine disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10672",
    "orpha_code": "268145",
    "disease_name": "Classic maple syrup urine disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10675",
    "orpha_code": "268184",
    "disease_name": "Thiamine-responsive maple syrup urine disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10674",
    "orpha_code": "268173",
    "disease_name": "Intermittent maple syrup urine disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3986",
    "orpha_code": "2980",
    "disease_name": "Acrootoocular syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3944",
    "orpha_code": "1848",
    "disease_name": "Renal agenesis, bilateral",
    "source": "16053904[PMID]_EUROCAT European surveillance of congenital anomalies 2009-2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10577",
    "orpha_code": "1848",
    "disease_name": "Renal agenesis, bilateral",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3938",
    "orpha_code": "2924",
    "disease_name": "Isolated polycystic liver disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3924",
    "orpha_code": "2896",
    "disease_name": "Pitt-Hopkins syndrome",
    "source": "ORPHANET_[EXPERT]_30677142[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3926",
    "orpha_code": "2900",
    "disease_name": "Leri pleonosteosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "3927",
    "orpha_code": "2905",
    "disease_name": "POEMS syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "3930",
    "orpha_code": "2911",
    "disease_name": "Poland syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3931",
    "orpha_code": "2911",
    "disease_name": "Poland syndrome",
    "source": "ORPHANET_EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9343",
    "orpha_code": "264580",
    "disease_name": "Glycogen storage disease due to liver phosphorylase kinase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9476",
    "orpha_code": "275803",
    "disease_name": "Pulmonary arterial hypertension associated with congenital heart disease",
    "source": "22362843[PMID]_16456139[PMID]_24629043[PMID]_21885399[PMID]_17360728[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9456",
    "orpha_code": "275777",
    "disease_name": "Heritable pulmonary arterial hypertension",
    "source": "16456139[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9467",
    "orpha_code": "275798",
    "disease_name": "Pulmonary arterial hypertension associated with connective tissue disease",
    "source": "24629043[PMID]_22362843[PMID]_16456139[PMID]_21885399[PMID]_17360728[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10676",
    "orpha_code": "275761",
    "disease_name": "Lysosomal acid lipase deficiency",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4184",
    "orpha_code": "3366",
    "disease_name": "Non-syndromic metopic craniosynostosis",
    "source": "21931569[PMID]_19326483[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17148",
    "orpha_code": "3366",
    "disease_name": "Non-syndromic metopic craniosynostosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9455",
    "orpha_code": "275766",
    "disease_name": "Idiopathic pulmonary arterial hypertension",
    "source": "16456139[PMID]_22362843[PMID]_18587690[PMID]_21885399[PMID]_17360728[PMID]_24629043[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13596",
    "orpha_code": "276145",
    "disease_name": "Malignant epithelial tumor of salivary glands",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10931",
    "orpha_code": "276161",
    "disease_name": "Multiple endocrine neoplasia",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4191",
    "orpha_code": "3384",
    "disease_name": "Common arterial trunk",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11411",
    "orpha_code": "3388",
    "disease_name": "Neural tube defect",
    "source": "26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1991-2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4157",
    "orpha_code": "3329",
    "disease_name": "Tibial aplasia-ectrodactyly syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12480",
    "orpha_code": "275555",
    "disease_name": "Preeclampsia",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4244",
    "orpha_code": "3465",
    "disease_name": "Worster-Drought syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4261",
    "orpha_code": "2749",
    "disease_name": "Oromandibular-limb hypogenesis syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4233",
    "orpha_code": "3453",
    "disease_name": "Autoimmune polyendocrinopathy type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9575",
    "orpha_code": "280379",
    "disease_name": "Erythropoietic uroporphyria associated with myeloid malignancy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4082",
    "orpha_code": "3184",
    "disease_name": "Steatocystoma multiplex-natal teeth syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4083",
    "orpha_code": "3193",
    "disease_name": "Supravalvular aortic stenosis",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4084",
    "orpha_code": "3193",
    "disease_name": "Supravalvular aortic stenosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4091",
    "orpha_code": "3201",
    "disease_name": "Ventricular extrasystoles with syncopal episodes-perodactyly-Robin sequence syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4065",
    "orpha_code": "3157",
    "disease_name": "Septo-optic dysplasia spectrum",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9557",
    "orpha_code": "280210",
    "disease_name": "Pelizaeus-Merzbacher disease, connatal form",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9558",
    "orpha_code": "280219",
    "disease_name": "Pelizaeus-Merzbacher disease, classic form",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9555",
    "orpha_code": "280200",
    "disease_name": "Microform holoprosencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9559",
    "orpha_code": "280224",
    "disease_name": "Pelizaeus-Merzbacher disease, transitional form",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11979",
    "orpha_code": "425",
    "disease_name": "Apolipoprotein A-I deficiency",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4140",
    "orpha_code": "3292",
    "disease_name": "Tel Hashomer camptodactyly syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11991",
    "orpha_code": "746",
    "disease_name": "Mitochondrial trifunctional protein deficiency",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4387",
    "orpha_code": "412",
    "disease_name": "Dysbetalipoproteinemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13736",
    "orpha_code": "743",
    "disease_name": "Severe hereditary thrombophilia due to congenital protein S deficiency",
    "source": "Pr Jenny GOUDEMAND [EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4399",
    "orpha_code": "325",
    "disease_name": "Congenital factor II deficiency",
    "source": "10595621[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10580",
    "orpha_code": "1930",
    "disease_name": "Herpes simplex virus encephalitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4425",
    "orpha_code": "158",
    "disease_name": "Systemic primary carnitine deficiency",
    "source": "22989098[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4432",
    "orpha_code": "820",
    "disease_name": "Sneddon syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4414",
    "orpha_code": "6",
    "disease_name": "3-methylcrotonyl-CoA carboxylase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11489",
    "orpha_code": "6",
    "disease_name": "3-methylcrotonyl-CoA carboxylase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4343",
    "orpha_code": "1524",
    "disease_name": "Craniomicromelic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10661",
    "orpha_code": "206572",
    "disease_name": "Overlap myositis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4363",
    "orpha_code": "633",
    "disease_name": "Laron syndrome",
    "source": "European Medicines Agency 2003[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4359",
    "orpha_code": "478",
    "disease_name": "Kallmann syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11681",
    "orpha_code": "822",
    "disease_name": "Hereditary spherocytosis",
    "source": "[EXPERT]_1554800[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4370",
    "orpha_code": "910",
    "disease_name": "Xeroderma pigmentosum",
    "source": "18329345[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4379",
    "orpha_code": "766",
    "disease_name": "Hemolytic anemia due to red cell pyruvate kinase deficiency",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4348",
    "orpha_code": "65",
    "disease_name": "Leber congenital amaurosis",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12040",
    "orpha_code": "321",
    "disease_name": "Multiple osteochondromas",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8650",
    "orpha_code": "206647",
    "disease_name": "Myotonic dystrophy",
    "source": "ORPHANET_25532075[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4353",
    "orpha_code": "110",
    "disease_name": "Bardet-Biedl syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8660",
    "orpha_code": "209335",
    "disease_name": "Autosomal dominant adult-onset proximal spinal muscular atrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8684",
    "orpha_code": "209964",
    "disease_name": "Solitary rectal ulcer syndrome",
    "source": "18188027[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8674",
    "orpha_code": "209916",
    "disease_name": "Extraskeletal myxoid chondrosarcoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4664",
    "orpha_code": "3286",
    "disease_name": "Catecholaminergic polymorphic ventricular tachycardia",
    "source": "23916535[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16523",
    "orpha_code": "210159",
    "disease_name": "Adult hepatocellular carcinoma",
    "source": "PMID: 22033323",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4670",
    "orpha_code": "1546",
    "disease_name": "Cryptococcosis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4667",
    "orpha_code": "2023",
    "disease_name": "Undifferentiated pleomorphic sarcoma",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10587",
    "orpha_code": "2023",
    "disease_name": "Undifferentiated pleomorphic sarcoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11965",
    "orpha_code": "3392",
    "disease_name": "Tularemia",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12930",
    "orpha_code": "3392",
    "disease_name": "Tularemia",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4678",
    "orpha_code": "2737",
    "disease_name": "Onchocerciasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4675",
    "orpha_code": "2034",
    "disease_name": "Filariasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10588",
    "orpha_code": "1902",
    "disease_name": "Ehrlichiosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4688",
    "orpha_code": "655",
    "disease_name": "Nephronophthisis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4686",
    "orpha_code": "2415",
    "disease_name": "Rare lymphatic malformation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4684",
    "orpha_code": "2591",
    "disease_name": "Infantile myofibromatosis",
    "source": "ISBN:443043469[OTHER]_23686518[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4711",
    "orpha_code": "35",
    "disease_name": "Propionic acidemia",
    "source": "23509210[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4703",
    "orpha_code": "407",
    "disease_name": "Glycine encephalopathy",
    "source": "European Medicines Agency 2002[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4692",
    "orpha_code": "137",
    "disease_name": "Congenital disorder of glycosylation",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4694",
    "orpha_code": "5",
    "disease_name": "Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11982",
    "orpha_code": "5",
    "disease_name": "Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4731",
    "orpha_code": "85",
    "disease_name": "Congenital dyserythropoietic anemia",
    "source": "20824457[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4732",
    "orpha_code": "85",
    "disease_name": "Congenital dyserythropoietic anemia",
    "source": "20824457[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4737",
    "orpha_code": "177",
    "disease_name": "Rhizomelic chondrodysplasia punctata",
    "source": "34229749[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4721",
    "orpha_code": "618",
    "disease_name": "Familial melanoma",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8722",
    "orpha_code": "213500",
    "disease_name": "Rare ovarian cancer",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4759",
    "orpha_code": "818",
    "disease_name": "Smith-Lemli-Opitz syndrome",
    "source": "[EXPERT]_10807690[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13636",
    "orpha_code": "213512",
    "disease_name": "Malignant mixed Mllerian tumor of the ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13632",
    "orpha_code": "213504",
    "disease_name": "Adenocarcinoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4741",
    "orpha_code": "209",
    "disease_name": "Cutis laxa",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4743",
    "orpha_code": "42",
    "disease_name": "Medium chain acyl-CoA dehydrogenase deficiency",
    "source": "Haute Autorit de Sant 2011[INST]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13625",
    "orpha_code": "213557",
    "disease_name": "Salivary gland type cancer of the breast",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13624",
    "orpha_code": "213531",
    "disease_name": "Metaplastic carcinoma of the breast",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13623",
    "orpha_code": "213528",
    "disease_name": "Rare adenocarcinoma of the breast",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4612",
    "orpha_code": "860",
    "disease_name": "Congenitally uncorrected transposition of the great arteries",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4610",
    "orpha_code": "185",
    "disease_name": "Scimitar syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4609",
    "orpha_code": "3189",
    "disease_name": "Congenital pulmonary valvar stenosis",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17155",
    "orpha_code": "3189",
    "disease_name": "Congenital pulmonary valvar stenosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "13626",
    "orpha_code": "213716",
    "disease_name": "Squamous cell carcinoma of the corpus uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13628",
    "orpha_code": "213746",
    "disease_name": "Transitional cell carcinoma of the corpus uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13630",
    "orpha_code": "213772",
    "disease_name": "Adenocarcinoma of the cervix uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13629",
    "orpha_code": "213767",
    "disease_name": "Squamous cell carcinoma of the cervix uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4640",
    "orpha_code": "782",
    "disease_name": "Axenfeld-Rieger syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8725",
    "orpha_code": "216675",
    "disease_name": "Transposition of the great arteries",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8742",
    "orpha_code": "216675",
    "disease_name": "Transposition of the great arteries",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10586",
    "orpha_code": "882",
    "disease_name": "Tyrosinemia type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17289",
    "orpha_code": "767",
    "disease_name": "Polyarteritis nodosa",
    "source": "9805179[PMID]_14872461[PMID]_17553910[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4512",
    "orpha_code": "2584",
    "disease_name": "Classic mycosis fungoides",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8780",
    "orpha_code": "217085",
    "disease_name": "Mucopolysaccharidosis type 2, severe form",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8779",
    "orpha_code": "217080",
    "disease_name": "Pulmonary fungal infections in patients deemed at risk",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8774",
    "orpha_code": "217074",
    "disease_name": "Rare carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8775",
    "orpha_code": "217074",
    "disease_name": "Rare carcinoma of pancreas",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8776",
    "orpha_code": "217074",
    "disease_name": "Rare carcinoma of pancreas",
    "source": "European Medicines Agency 2013[INST]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8773",
    "orpha_code": "217071",
    "disease_name": "Renal cell carcinoma",
    "source": "European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13644",
    "orpha_code": "217071",
    "disease_name": "Renal cell carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8772",
    "orpha_code": "217067",
    "disease_name": "Pouchitis",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8771",
    "orpha_code": "217064",
    "disease_name": "5-fluorouracil poisoning",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8791",
    "orpha_code": "217340",
    "disease_name": "17q21.31 microduplication syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4544",
    "orpha_code": "3260",
    "disease_name": "Idiopathic hypereosinophilic syndrome",
    "source": "ORPHANET_22740191[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10581",
    "orpha_code": "2086",
    "disease_name": "Optic pathway glioma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11953",
    "orpha_code": "340",
    "disease_name": "Hemorrhagic fever-renal syndrome",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12910",
    "orpha_code": "340",
    "disease_name": "Hemorrhagic fever-renal syndrome",
    "source": "European Medicines Agency 2004[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4551",
    "orpha_code": "1456",
    "disease_name": "Middle aortic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4552",
    "orpha_code": "1456",
    "disease_name": "Middle aortic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4553",
    "orpha_code": "1457",
    "disease_name": "Aorta coarctation",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4547",
    "orpha_code": "980",
    "disease_name": "Absence of the pulmonary artery",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4584",
    "orpha_code": "2299",
    "disease_name": "Aortic arch interruption",
    "source": "24457106[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10583",
    "orpha_code": "2299",
    "disease_name": "Aortic arch interruption",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10585",
    "orpha_code": "3427",
    "disease_name": "Double outlet left ventricle",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10584",
    "orpha_code": "3426",
    "disease_name": "Double outlet right ventricle",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4582",
    "orpha_code": "422",
    "disease_name": "Idiopathic/heritable pulmonary arterial hypertension",
    "source": "16456139[PMID]_24629043[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10582",
    "orpha_code": "2038",
    "disease_name": "Pulmonary arteriovenous malformation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4442",
    "orpha_code": "282",
    "disease_name": "Frontotemporal dementia",
    "source": "20971753[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4440",
    "orpha_code": "331",
    "disease_name": "Congenital factor XIII deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4441",
    "orpha_code": "331",
    "disease_name": "Congenital factor XIII deficiency",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4443",
    "orpha_code": "542",
    "disease_name": "Primary cutaneous lymphoma",
    "source": "15692063[PMID]_16192622[PMID]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4444",
    "orpha_code": "542",
    "disease_name": "Primary cutaneous lymphoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11967",
    "orpha_code": "707",
    "disease_name": "Plague",
    "source": "European Centre for Disease prevention and Control 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4434",
    "orpha_code": "335",
    "disease_name": "Congenital fibrinogen deficiency",
    "source": "National haemophilia foundation[OTHER]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4456",
    "orpha_code": "2157",
    "disease_name": "Histidinemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8817",
    "orpha_code": "220386",
    "disease_name": "Semilobar holoprosencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4476",
    "orpha_code": "927",
    "disease_name": "Hyperammonemia due to N-acetylglutamate synthase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4468",
    "orpha_code": "212",
    "disease_name": "Cystathioninuria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4469",
    "orpha_code": "470",
    "disease_name": "Lysinuric protein intolerance",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 3.8,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17513",
    "orpha_code": "2965",
    "disease_name": "Prolactinoma",
    "source": "16968795[PMID]_ 19650784[PMID]_ 19968031[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10727",
    "orpha_code": "538",
    "disease_name": "Lymphangioleiomyomatosis",
    "source": "21764810[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8849",
    "orpha_code": "225154",
    "disease_name": "Familial infantile bilateral striatal necrosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8848",
    "orpha_code": "225147",
    "disease_name": "Sporadic infantile bilateral striatal necrosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8843",
    "orpha_code": "223727",
    "disease_name": "Bone sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8844",
    "orpha_code": "223727",
    "disease_name": "Bone sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4923",
    "orpha_code": "3398",
    "disease_name": "Thymic epithelial neoplasm",
    "source": "[EXPERT]_RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10590",
    "orpha_code": "3398",
    "disease_name": "Thymic epithelial neoplasm",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4925",
    "orpha_code": "547",
    "disease_name": "Non-Hodgkin lymphoma",
    "source": "22835603[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4926",
    "orpha_code": "547",
    "disease_name": "Non-Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4920",
    "orpha_code": "842",
    "disease_name": "Testicular seminomatous germ cell tumor",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4921",
    "orpha_code": "842",
    "disease_name": "Testicular seminomatous germ cell tumor",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10664",
    "orpha_code": "227796",
    "disease_name": "Fundus albipunctatus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "8863",
    "orpha_code": "228113",
    "disease_name": "Anal fistula",
    "source": "DOI:10.12998/wjcc.v7.i14.1795[OTHER]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4927",
    "orpha_code": "389",
    "disease_name": "Langerhans cell histiocytosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4901",
    "orpha_code": "616",
    "disease_name": "Medulloblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4902",
    "orpha_code": "616",
    "disease_name": "Medulloblastoma",
    "source": "European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4896",
    "orpha_code": "301",
    "disease_name": "Ependymal tumor",
    "source": "22227039[PMID]_22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4897",
    "orpha_code": "301",
    "disease_name": "Ependymal tumor",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4898",
    "orpha_code": "301",
    "disease_name": "Ependymal tumor",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4894",
    "orpha_code": "541",
    "disease_name": "Primary cutaneous CD30+ T-cell lymphoproliferative disease",
    "source": "Institut de Veille Sanitaire 1990[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4890",
    "orpha_code": "543",
    "disease_name": "Burkitt lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2003[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4917",
    "orpha_code": "319",
    "disease_name": "Skeletal Ewing sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4918",
    "orpha_code": "319",
    "disease_name": "Skeletal Ewing sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4913",
    "orpha_code": "668",
    "disease_name": "Osteosarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4914",
    "orpha_code": "668",
    "disease_name": "Osteosarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4915",
    "orpha_code": "668",
    "disease_name": "Osteosarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10663",
    "orpha_code": "227510",
    "disease_name": "Multiple system atrophy, cerebellar type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4911",
    "orpha_code": "94",
    "disease_name": "Astrocytoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4912",
    "orpha_code": "94",
    "disease_name": "Astrocytoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4906",
    "orpha_code": "360",
    "disease_name": "Glioblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2003[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8851",
    "orpha_code": "226292",
    "disease_name": "Permanent congenital hypothyroidism",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4870",
    "orpha_code": "513",
    "disease_name": "Acute lymphoblastic leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4874",
    "orpha_code": "513",
    "disease_name": "Acute lymphoblastic leukemia",
    "source": "European Medicines Agency 2005[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4875",
    "orpha_code": "1957",
    "disease_name": "Esthesioneuroblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4876",
    "orpha_code": "1957",
    "disease_name": "Esthesioneuroblastoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4877",
    "orpha_code": "2030",
    "disease_name": "Fibrosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8853",
    "orpha_code": "226295",
    "disease_name": "Primary congenital hypothyroidism",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4866",
    "orpha_code": "758",
    "disease_name": "Pseudoxanthoma elasticum",
    "source": "22209248[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4868",
    "orpha_code": "1501",
    "disease_name": "Adrenocortical carcinoma",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4869",
    "orpha_code": "1501",
    "disease_name": "Adrenocortical carcinoma",
    "source": "22796286[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4883",
    "orpha_code": "391",
    "disease_name": "Classic Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe [REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4885",
    "orpha_code": "391",
    "disease_name": "Classic Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4886",
    "orpha_code": "391",
    "disease_name": "Classic Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2010[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4857",
    "orpha_code": "503",
    "disease_name": "Larsen syndrome",
    "source": "[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4858",
    "orpha_code": "503",
    "disease_name": "Larsen syndrome",
    "source": "[EXPERT]_EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4851",
    "orpha_code": "2542",
    "disease_name": "Isolated microphthalmia-anophthalmia-coloboma",
    "source": "EUROCAT European surveillance of congenital anomalies 2000-2016[REG]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4852",
    "orpha_code": "2542",
    "disease_name": "Isolated microphthalmia-anophthalmia-coloboma",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4843",
    "orpha_code": "3280",
    "disease_name": "Syringomyelia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4864",
    "orpha_code": "223",
    "disease_name": "Arginine vasopressin resistance",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4834",
    "orpha_code": "521",
    "disease_name": "Chronic myeloid leukemia",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4836",
    "orpha_code": "521",
    "disease_name": "Chronic myeloid leukemia",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4837",
    "orpha_code": "521",
    "disease_name": "Chronic myeloid leukemia",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4833",
    "orpha_code": "132",
    "disease_name": "Hereditary butyrylcholinesterase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10732",
    "orpha_code": "1172",
    "disease_name": "Autosomal recessive cerebellar ataxia",
    "source": "19440741[PMID]_19339254[PMID]_23609960[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4839",
    "orpha_code": "2345",
    "disease_name": "Isolated Klippel-Feil syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4840",
    "orpha_code": "2345",
    "disease_name": "Isolated Klippel-Feil syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4838",
    "orpha_code": "1333",
    "disease_name": "Familial pancreatic carcinoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4831",
    "orpha_code": "2781",
    "disease_name": "Osteopetrosis and related disorders",
    "source": "16307387[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8905",
    "orpha_code": "228371",
    "disease_name": "Foodborne botulism",
    "source": "21495856[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8902",
    "orpha_code": "228312",
    "disease_name": "Autoimmune hemolytic anemia, cold type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8888",
    "orpha_code": "228264",
    "disease_name": "Papular elastorrhexis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12921",
    "orpha_code": "328",
    "disease_name": "Congenital factor X deficiency",
    "source": "European Medicines Agency 2008[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4814",
    "orpha_code": "256",
    "disease_name": "Early-onset generalized limb-onset dystonia",
    "source": "17129379[PMID]_23596437[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4811",
    "orpha_code": "441",
    "disease_name": "Pure autonomic failure",
    "source": "European Medicines Agency 2007[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4810",
    "orpha_code": "1576",
    "disease_name": "Infantile bilateral striatal necrosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4803",
    "orpha_code": "2073",
    "disease_name": "Narcolepsy type 1",
    "source": "24849861[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4795",
    "orpha_code": "1866",
    "disease_name": "Focal, segmental or multifocal dystonia",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4796",
    "orpha_code": "1866",
    "disease_name": "Focal, segmental or multifocal dystonia",
    "source": "11127535[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4794",
    "orpha_code": "809",
    "disease_name": "Mixed connective tissue disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8960",
    "orpha_code": "231183",
    "disease_name": "Usher syndrome type 3",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8958",
    "orpha_code": "231178",
    "disease_name": "Usher syndrome type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8956",
    "orpha_code": "231169",
    "disease_name": "Usher syndrome type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8952",
    "orpha_code": "231147",
    "disease_name": "Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12913",
    "orpha_code": "231080",
    "disease_name": "High-grade dysplasia in patients with Barrett esophagus",
    "source": "European Medicines Agency 2002[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4783",
    "orpha_code": "3318",
    "disease_name": "Essential thrombocythemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13686",
    "orpha_code": "3318",
    "disease_name": "Essential thrombocythemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8944",
    "orpha_code": "230857",
    "disease_name": "Ehlers-Danlos/osteogenesis imperfecta syndrome",
    "source": "ORPHANET_23692737[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4774",
    "orpha_code": "913",
    "disease_name": "Zollinger-Ellison syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4775",
    "orpha_code": "913",
    "disease_name": "Zollinger-Ellison syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4768",
    "orpha_code": "519",
    "disease_name": "Acute myeloid leukemia",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4769",
    "orpha_code": "519",
    "disease_name": "Acute myeloid leukemia",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4770",
    "orpha_code": "519",
    "disease_name": "Acute myeloid leukemia",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10666",
    "orpha_code": "235936",
    "disease_name": "Familial hyperaldosteronism",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4929",
    "orpha_code": "285",
    "disease_name": "Hypermobile Ehlers-Danlos syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4941",
    "orpha_code": "3394",
    "disease_name": "Soft tissue sarcoma",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13658",
    "orpha_code": "3394",
    "disease_name": "Soft tissue sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9002",
    "orpha_code": "238517",
    "disease_name": "Hypotonia-cystinuria type 1 syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8997",
    "orpha_code": "238468",
    "disease_name": "Hypohidrotic ectodermal dysplasia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12932",
    "orpha_code": "238624",
    "disease_name": "Idiopathic intracranial hypertension",
    "source": "European Medicines Agency 2016[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9017",
    "orpha_code": "238621",
    "disease_name": "Ileal pouch anal anastomosis related faecal incontinence",
    "source": "European Medicines Agency 2009[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9037",
    "orpha_code": "240071",
    "disease_name": "Classic progressive supranuclear palsy syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9040",
    "orpha_code": "240103",
    "disease_name": "Progressive supranuclear palsy-corticobasal syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9039",
    "orpha_code": "240094",
    "disease_name": "Progressive supranuclear palsy-pure akinesia with gait freezing syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12926",
    "orpha_code": "331206",
    "disease_name": "Severe combined immunodeficiency due to complete RAG1/2 deficiency",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10226",
    "orpha_code": "330064",
    "disease_name": "Chronic actinic dermatitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10210",
    "orpha_code": "330012",
    "disease_name": "High altitude pulmonary edema",
    "source": "European Medicines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10211",
    "orpha_code": "330015",
    "disease_name": "Lead poisoning",
    "source": "European Medicines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10213",
    "orpha_code": "330021",
    "disease_name": "Mercury poisoning",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10223",
    "orpha_code": "330058",
    "disease_name": "Hydroa vacciniforme",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12221",
    "orpha_code": "329918",
    "disease_name": "C3 glomerulopathy",
    "source": "27056062[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10150",
    "orpha_code": "329217",
    "disease_name": "Cerebral sinovenous thrombosis",
    "source": "15858188[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.5,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4950",
    "orpha_code": "329",
    "disease_name": "Congenital factor XI deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10734",
    "orpha_code": "1243",
    "disease_name": "Best vitelliform macular dystrophy",
    "source": "ORPHANET_22633354[PMID]_4448697[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11947",
    "orpha_code": "324625",
    "disease_name": "Chikungunya",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13645",
    "orpha_code": "319276",
    "disease_name": "Clear cell renal carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11960",
    "orpha_code": "319251",
    "disease_name": "Rift valley fever",
    "source": "European Centre for Disease prevention and Control 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13649",
    "orpha_code": "319319",
    "disease_name": "Renal medullary carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13646",
    "orpha_code": "319298",
    "disease_name": "Papillary renal cell carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13647",
    "orpha_code": "319303",
    "disease_name": "Chromophobe renal cell carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11952",
    "orpha_code": "319218",
    "disease_name": "Ebola hemorrhagic fever",
    "source": "European Centre for Disease prevention and Control 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11981",
    "orpha_code": "319218",
    "disease_name": "Ebola hemorrhagic fever",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10049",
    "orpha_code": "317430",
    "disease_name": "Combined immunodeficiency due to STIM1 deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10046",
    "orpha_code": "315311",
    "disease_name": "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10044",
    "orpha_code": "315306",
    "disease_name": "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10045",
    "orpha_code": "315306",
    "disease_name": "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10033",
    "orpha_code": "314918",
    "disease_name": "Mild Canavan disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12915",
    "orpha_code": "314701",
    "disease_name": "Primary systemic amyloidosis",
    "source": "European Medicines Agency 2003[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10690",
    "orpha_code": "369867",
    "disease_name": "Autosomal recessive intermediate Charcot-Marie-Tooth disease type C",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10689",
    "orpha_code": "364033",
    "disease_name": "Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "4974",
    "orpha_code": "1048",
    "disease_name": "Isolated anencephaly/exencephaly",
    "source": "EUROCAT European surveillance of congenital anomalies [REG] _ORPHANET_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4975",
    "orpha_code": "1048",
    "disease_name": "Isolated anencephaly/exencephaly",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4952",
    "orpha_code": "823",
    "disease_name": "Spina bifida and other spinal dysraphisms",
    "source": "EUROCAT European surveillance of congenital anomalies 2007-2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4953",
    "orpha_code": "823",
    "disease_name": "Spina bifida and other spinal dysraphisms",
    "source": "EUROCAT European surveillance of congenital anomalies 2007-2011[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10406",
    "orpha_code": "363958",
    "disease_name": "17q21.31 microdeletion syndrome",
    "source": "26306646[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10688",
    "orpha_code": "363727",
    "disease_name": "X-linked dyserythropoietic anemia with abnormal platelets and neutropenia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13651",
    "orpha_code": "363579",
    "disease_name": "Extragonadal germ cell tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10361",
    "orpha_code": "363494",
    "disease_name": "Non-seminomatous germ cell tumor of testis",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10362",
    "orpha_code": "363494",
    "disease_name": "Non-seminomatous germ cell tumor of testis",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10355",
    "orpha_code": "363478",
    "disease_name": "Paratesticular adenocarcinoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10356",
    "orpha_code": "363478",
    "disease_name": "Paratesticular adenocarcinoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13643",
    "orpha_code": "363478",
    "disease_name": "Paratesticular adenocarcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10352",
    "orpha_code": "363472",
    "disease_name": "Tumor of testis and paratestis",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10353",
    "orpha_code": "363472",
    "disease_name": "Tumor of testis and paratestis",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10359",
    "orpha_code": "363489",
    "disease_name": "Sex cord-stromal tumor of testis",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10360",
    "orpha_code": "363489",
    "disease_name": "Sex cord-stromal tumor of testis",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10357",
    "orpha_code": "363483",
    "disease_name": "Testicular teratoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10358",
    "orpha_code": "363483",
    "disease_name": "Testicular teratoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10687",
    "orpha_code": "357502",
    "disease_name": "Idiopathic nephrotic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10318",
    "orpha_code": "357034",
    "disease_name": "Non-hereditary retinoblastoma",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10269",
    "orpha_code": "352657",
    "disease_name": "Hereditary benign intraepithelial dyskeratosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10686",
    "orpha_code": "352723",
    "disease_name": "Attenuated Chdiak-Higashi syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13348",
    "orpha_code": "353253",
    "disease_name": "Burning mouth syndrome",
    "source": "ORPHANET_10478959[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10304",
    "orpha_code": "353334",
    "disease_name": "Congenital retinal arteriovenous communication",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9757",
    "orpha_code": "293725",
    "disease_name": "Blepharophimosis-intellectual disability syndrome, Verloes type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9756",
    "orpha_code": "293707",
    "disease_name": "Blepharophimosis-intellectual disability syndrome, MKB type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9800",
    "orpha_code": "294963",
    "disease_name": "Popliteal pterygium syndrome",
    "source": "2352260[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9744",
    "orpha_code": "293355",
    "disease_name": "Methylmalonic acidemia without homocystinuria",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5008",
    "orpha_code": "811",
    "disease_name": "Shwachman-Diamond syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9737",
    "orpha_code": "293199",
    "disease_name": "Pleomorphic rhabdomyosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9738",
    "orpha_code": "293199",
    "disease_name": "Pleomorphic rhabdomyosarcoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9739",
    "orpha_code": "293202",
    "disease_name": "Epithelioid sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9740",
    "orpha_code": "293202",
    "disease_name": "Epithelioid sarcoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12470",
    "orpha_code": "2459",
    "disease_name": "Mansonelliasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4988",
    "orpha_code": "2404",
    "disease_name": "Loiasis",
    "source": "22784545[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10735",
    "orpha_code": "829",
    "disease_name": "Adult-onset Still disease",
    "source": "ORPHANET_16467042[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4997",
    "orpha_code": "1183",
    "disease_name": "Opsoclonus-myoclonus syndrome",
    "source": "[EXPERT]_19423368[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5003",
    "orpha_code": "2686",
    "disease_name": "Cyclic neutropenia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12471",
    "orpha_code": "231",
    "disease_name": "Dracunculiasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12468",
    "orpha_code": "2035",
    "disease_name": "Lymphatic filariasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9675",
    "orpha_code": "284417",
    "disease_name": "Phosphoserine aminotransferase deficiency, infantile/juvenile form",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9691",
    "orpha_code": "289307",
    "disease_name": "Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13870",
    "orpha_code": "289390",
    "disease_name": "Primary Sjgren disease",
    "source": "25387476[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9687",
    "orpha_code": "289157",
    "disease_name": "Hypocalcemic vitamin D-dependent rickets",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17089",
    "orpha_code": "280921",
    "disease_name": "Idiopathic panuveitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17090",
    "orpha_code": "280921",
    "disease_name": "Idiopathic panuveitis",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9635",
    "orpha_code": "281097",
    "disease_name": "Autosomal recessive congenital ichthyosis",
    "source": "8006437[PMID]_European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9633",
    "orpha_code": "281090",
    "disease_name": "Syndromic recessive X-linked ichthyosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9652",
    "orpha_code": "284149",
    "disease_name": "Craniosynostosis-dental anomalies",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9656",
    "orpha_code": "284180",
    "disease_name": "Xp22.13p22.2 duplication syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9660",
    "orpha_code": "284247",
    "disease_name": "Familial retinal arterial macroaneurysm",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9659",
    "orpha_code": "284232",
    "disease_name": "Autosomal dominant Charcot-Marie-Tooth disease type 2O",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9662",
    "orpha_code": "284271",
    "disease_name": "Autosomal recessive cerebellar ataxia-psychomotor delay syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9665",
    "orpha_code": "284324",
    "disease_name": "Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9663",
    "orpha_code": "284282",
    "disease_name": "Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9666",
    "orpha_code": "284332",
    "disease_name": "Infantile-onset autosomal recessive nonprogressive cerebellar ataxia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9673",
    "orpha_code": "284400",
    "disease_name": "Small cell carcinoma of the bladder",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9674",
    "orpha_code": "284400",
    "disease_name": "Small cell carcinoma of the bladder",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12234",
    "orpha_code": "282166",
    "disease_name": "Inherited Creutzfeldt-Jakob disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9921",
    "orpha_code": "313838",
    "disease_name": "Coats plus syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12924",
    "orpha_code": "308386",
    "disease_name": "Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A",
    "source": "ORPHANET_European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14721",
    "orpha_code": "309015",
    "disease_name": "Familial lipoprotein lipase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10681",
    "orpha_code": "308552",
    "disease_name": "Glycogen storage disease due to acid maltase deficiency, infantile onset",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "9908",
    "orpha_code": "309294",
    "disease_name": "Sialidosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10872",
    "orpha_code": "309294",
    "disease_name": "Sialidosis",
    "source": "10480370[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10684",
    "orpha_code": "309297",
    "disease_name": "Mucopolysaccharidosis type 4A",
    "source": "European Medicines Agency 2009[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13773",
    "orpha_code": "309152",
    "disease_name": "GM2 gangliosidosis",
    "source": "European Medecines Agency 2017[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9852",
    "orpha_code": "300557",
    "disease_name": "Carcinoma of the ampulla of Vater",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10678",
    "orpha_code": "300865",
    "disease_name": "Primary cutaneous anaplastic large cell lymphoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10679",
    "orpha_code": "300895",
    "disease_name": "ALK-positive anaplastic large cell lymphoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "9861",
    "orpha_code": "300605",
    "disease_name": "Juvenile amyotrophic lateral sclerosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11971",
    "orpha_code": "300912",
    "disease_name": "Marginal zone lymphoma",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13698",
    "orpha_code": "300912",
    "disease_name": "Marginal zone lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10680",
    "orpha_code": "306516",
    "disease_name": "Primary hypomagnesemia with hypercalciuria and nephrocalcinosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12912",
    "orpha_code": "306644",
    "disease_name": "Complication after organ transplantation",
    "source": "European Medicines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9828",
    "orpha_code": "300385",
    "disease_name": "Pituitary carcinoma",
    "source": "22361014[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "9829",
    "orpha_code": "300385",
    "disease_name": "Pituitary carcinoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12619",
    "orpha_code": "464370",
    "disease_name": "Neonatal alloimmune neutropenia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12621",
    "orpha_code": "464458",
    "disease_name": "Paracetamol poisoning",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12104",
    "orpha_code": "454831",
    "disease_name": "Acute radiation syndrome",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12117",
    "orpha_code": "454836",
    "disease_name": "Avian influenza",
    "source": "ORPHANET_World Health Organization 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12111",
    "orpha_code": "454723",
    "disease_name": "Endometrioid carcinoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12109",
    "orpha_code": "454718",
    "disease_name": "Holmes-Adie syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12107",
    "orpha_code": "454714",
    "disease_name": "Plasma cell leukemia",
    "source": "20664057[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12235",
    "orpha_code": "454700",
    "disease_name": "Acquired Creutzfeldt-Jakob disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12170",
    "orpha_code": "449280",
    "disease_name": "Scedosporiosis",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11984",
    "orpha_code": "449285",
    "disease_name": "Snakebite envenomation",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12171",
    "orpha_code": "449266",
    "disease_name": "Pleural empyema",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12306",
    "orpha_code": "458718",
    "disease_name": "Idiopathic spontaneous coronary artery dissection",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12544",
    "orpha_code": "402823",
    "disease_name": "Hepatitis delta",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15260",
    "orpha_code": "401920",
    "disease_name": "Fibrolamellar hepatocellular carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11262",
    "orpha_code": "411527",
    "disease_name": "Central retinal vein occlusion",
    "source": "European Medecines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10918",
    "orpha_code": "411629",
    "disease_name": "Infantile nephropathic cystinosis",
    "source": "[EXPERT]_12110740[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10942",
    "orpha_code": "411634",
    "disease_name": "Juvenile nephropathic cystinosis",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12661",
    "orpha_code": "411703",
    "disease_name": "Pulmonary non-tuberculous mycobacterial infection",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10812",
    "orpha_code": "391490",
    "disease_name": "Adult-onset myasthenia gravis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10692",
    "orpha_code": "391487",
    "disease_name": "STAT1-related autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome",
    "source": "ORPHANET_23534974[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12923",
    "orpha_code": "391655",
    "disease_name": "Off-periods in Parkinson disease not responding to oral treatment",
    "source": "European Medicines Agency 2004[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10691",
    "orpha_code": "391384",
    "disease_name": "Familial episodic pain syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11060",
    "orpha_code": "398058",
    "disease_name": "Squamous cell carcinoma of the penis",
    "source": "22119351[PMID]_RARECARE Surveillance of Rare Cancers in Europe 2003[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11059",
    "orpha_code": "398053",
    "disease_name": "Adenocarcinoma of the penis",
    "source": "22119351[PMID]_RARECARE Surveillance of Rare Cancers in Europe 2003[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11056",
    "orpha_code": "398043",
    "disease_name": "Malignant tumor of penis",
    "source": "26076979[PMID]_IARC International Agency for research on cancer 2002[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13640",
    "orpha_code": "398987",
    "disease_name": "Malignant teratoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13631",
    "orpha_code": "398934",
    "disease_name": "Malignant epithelial tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13633",
    "orpha_code": "398961",
    "disease_name": "Mucinous adenocarcinoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13635",
    "orpha_code": "398940",
    "disease_name": "Malignant non-epithelial tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13634",
    "orpha_code": "398971",
    "disease_name": "Clear cell adenocarcinoma of the ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12925",
    "orpha_code": "438279",
    "disease_name": "Human infection by orthopoxvirus",
    "source": "European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12460",
    "orpha_code": "438266",
    "disease_name": "Progressive encephalomyelitis with rigidity and myoclonus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5077",
    "orpha_code": "3008",
    "disease_name": "Pyruvate carboxylase deficiency",
    "source": "ISBN:79130356[OTHER]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12368",
    "orpha_code": "443192",
    "disease_name": "Classic stiff person syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5082",
    "orpha_code": "298",
    "disease_name": "Mitochondrial neurogastrointestinal encephalomyopathy",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5083",
    "orpha_code": "396",
    "disease_name": "Chronic hiccup",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5080",
    "orpha_code": "552",
    "disease_name": "MODY",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16534",
    "orpha_code": "854",
    "disease_name": "Non-malignant and non-cirrhotic portal vein thrombosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "16536",
    "orpha_code": "854",
    "disease_name": "Non-malignant and non-cirrhotic portal vein thrombosis",
    "source": "21039677[PMID]_28180235[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5072",
    "orpha_code": "130",
    "disease_name": "Brugada syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5074",
    "orpha_code": "277",
    "disease_name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
    "source": "20301656[PMID]_ ORPHANET_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5075",
    "orpha_code": "277",
    "disease_name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12459",
    "orpha_code": "443804",
    "disease_name": "Focal stiff limb syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11451",
    "orpha_code": "444490",
    "disease_name": "Familial chylomicronemia syndrome",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13599",
    "orpha_code": "418959",
    "disease_name": "Squamous cell carcinoma of the stomach",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13597",
    "orpha_code": "418945",
    "disease_name": "Carcinoma of esophagus, salivary gland type",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13598",
    "orpha_code": "418951",
    "disease_name": "Undifferentiated carcinoma of esophagus",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13612",
    "orpha_code": "424065",
    "disease_name": "Pancreatic solid pseudopapillary neoplasm",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13611",
    "orpha_code": "424058",
    "disease_name": "Intraductal papillary mucinous carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15221",
    "orpha_code": "424080",
    "disease_name": "Undifferentiated carcinoma with osteoclast-like giant cells of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13613",
    "orpha_code": "424073",
    "disease_name": "Serous cystadenocarcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13607",
    "orpha_code": "424016",
    "disease_name": "Adenocarcinoma of the anal canal",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13606",
    "orpha_code": "424019",
    "disease_name": "Squamous cell carcinoma of the anal canal",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13608",
    "orpha_code": "424039",
    "disease_name": "Squamous cell carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13610",
    "orpha_code": "424053",
    "disease_name": "Mucinous cystadenocarcinoma of the pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "17246",
    "orpha_code": "424053",
    "disease_name": "Mucinous cystadenocarcinoma of the pancreas",
    "source": "RARECARE",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "13609",
    "orpha_code": "424046",
    "disease_name": "Acinar cell carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13603",
    "orpha_code": "423968",
    "disease_name": "Squamous cell carcinoma of the small intestine",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13604",
    "orpha_code": "423994",
    "disease_name": "Squamous cell carcinoma of the colon",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13605",
    "orpha_code": "424002",
    "disease_name": "Squamous cell carcinoma of the rectum",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13601",
    "orpha_code": "423786",
    "disease_name": "Undifferentiated carcinoma of stomach",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13615",
    "orpha_code": "424943",
    "disease_name": "Adenocarcinoma of the liver and intrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13616",
    "orpha_code": "424970",
    "disease_name": "Undifferentiated carcinoma of liver and intrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13620",
    "orpha_code": "424991",
    "disease_name": "Adenocarcinoma of the gallbladder and extrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13621",
    "orpha_code": "424996",
    "disease_name": "Squamous cell carcinoma of gallbladder and extrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13617",
    "orpha_code": "424975",
    "disease_name": "Squamous cell carcinoma of liver and intrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13618",
    "orpha_code": "424982",
    "disease_name": "Biliary cystadenocarcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5371",
    "orpha_code": "26793",
    "disease_name": "Very long chain acyl-CoA dehydrogenase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5381",
    "orpha_code": "29072",
    "disease_name": "Hereditary pheochromocytoma-paraganglioma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5385",
    "orpha_code": "29073",
    "disease_name": "Multiple myeloma",
    "source": "World Health Organization 2008[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5387",
    "orpha_code": "29073",
    "disease_name": "Multiple myeloma",
    "source": "World Health Organization 2008[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5395",
    "orpha_code": "30391",
    "disease_name": "Isolated biliary atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5396",
    "orpha_code": "30391",
    "disease_name": "Isolated biliary atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5328",
    "orpha_code": "320",
    "disease_name": "Apparent mineralocorticoid excess",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5324",
    "orpha_code": "590",
    "disease_name": "Congenital myasthenic syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16537",
    "orpha_code": "756",
    "disease_name": "Pseudohypoaldosteronism type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5354",
    "orpha_code": "544",
    "disease_name": "Diffuse large B-cell lymphoma",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13697",
    "orpha_code": "544",
    "disease_name": "Diffuse large B-cell lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5356",
    "orpha_code": "545",
    "disease_name": "Follicular lymphoma",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13699",
    "orpha_code": "545",
    "disease_name": "Follicular lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5358",
    "orpha_code": "88",
    "disease_name": "Idiopathic aplastic anemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5333",
    "orpha_code": "102",
    "disease_name": "Multiple system atrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5346",
    "orpha_code": "824",
    "disease_name": "Primary myelofibrosis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5347",
    "orpha_code": "824",
    "disease_name": "Primary myelofibrosis",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5349",
    "orpha_code": "729",
    "disease_name": "Polycythemia vera",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5350",
    "orpha_code": "729",
    "disease_name": "Polycythemia vera",
    "source": "[EXPERT]_European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5361",
    "orpha_code": "26106",
    "disease_name": "Hereditary diffuse gastric cancer",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14796",
    "orpha_code": "26790",
    "disease_name": "Pseudomyxoma peritonei",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10595",
    "orpha_code": "26791",
    "disease_name": "Multiple acyl-CoA dehydrogenase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5284",
    "orpha_code": "674",
    "disease_name": "Accessory pancreas",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5293",
    "orpha_code": "353",
    "disease_name": "Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5296",
    "orpha_code": "219",
    "disease_name": "Delta-sarcoglycan-related limb-girdle muscular dystrophy R6",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5292",
    "orpha_code": "119",
    "disease_name": "Beta-sarcoglycan-related limb-girdle muscular dystrophy R4",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5307",
    "orpha_code": "899",
    "disease_name": "Walker-Warburg syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5308",
    "orpha_code": "899",
    "disease_name": "Walker-Warburg syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5302",
    "orpha_code": "268",
    "disease_name": "Dysferlin-related limb-girdle muscular dystrophy R2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5321",
    "orpha_code": "263",
    "disease_name": "Limb-girdle muscular dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5315",
    "orpha_code": "609",
    "disease_name": "Tibial muscular dystrophy",
    "source": "24395473[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15408",
    "orpha_code": "505652",
    "disease_name": "CDKL5-deficiency disorder",
    "source": "EpiCARE[EXPERT]_31302675[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13797",
    "orpha_code": "494547",
    "disease_name": "Squamous cell carcinoma of the hypopharynx",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13798",
    "orpha_code": "494550",
    "disease_name": "Squamous cell carcinoma of the larynx",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5089",
    "orpha_code": "68",
    "disease_name": "Amoebiasis due to free-living amoebae",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10593",
    "orpha_code": "781",
    "disease_name": "Q fever",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11958",
    "orpha_code": "781",
    "disease_name": "Q fever",
    "source": "European Centre for Disease prevention and Control 2012-2016[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5094",
    "orpha_code": "128",
    "disease_name": "Diphyllobothriasis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5092",
    "orpha_code": "108",
    "disease_name": "Babesiosis",
    "source": "emedicine[OTHER]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13803",
    "orpha_code": "500478",
    "disease_name": "Squamous cell carcinoma of the oropharynx",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5121",
    "orpha_code": "518",
    "disease_name": "Acute megakaryoblastic leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13682",
    "orpha_code": "518",
    "disease_name": "Acute megakaryoblastic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5119",
    "orpha_code": "514",
    "disease_name": "Acute monoblastic/monocytic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5120",
    "orpha_code": "514",
    "disease_name": "Acute monoblastic/monocytic leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5118",
    "orpha_code": "517",
    "disease_name": "Acute myelomonocytic leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13680",
    "orpha_code": "517",
    "disease_name": "Acute myelomonocytic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5096",
    "orpha_code": "400",
    "disease_name": "Cystic echinococcosis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5115",
    "orpha_code": "520",
    "disease_name": "Acute promyelocytic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5113",
    "orpha_code": "450",
    "disease_name": "Heterotaxia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5107",
    "orpha_code": "224",
    "disease_name": "Neonatal diabetes mellitus",
    "source": "21953423[PMID]_19499210[PMID]_20546293[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13800",
    "orpha_code": "502363",
    "disease_name": "Squamous cell carcinoma of the oral cavity",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]_28687376[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5245",
    "orpha_code": "873",
    "disease_name": "Desmoid tumor",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12872",
    "orpha_code": "703",
    "disease_name": "Bullous pemphigoid",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5280",
    "orpha_code": "722",
    "disease_name": "Hypoplasminogenemia",
    "source": "32001536[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5273",
    "orpha_code": "1332",
    "disease_name": "Medullary thyroid carcinoma",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5275",
    "orpha_code": "1332",
    "disease_name": "Medullary thyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5270",
    "orpha_code": "877",
    "disease_name": "Neuroendocrine neoplasm",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5261",
    "orpha_code": "467",
    "disease_name": "Non-acquired combined pituitary hormone deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5262",
    "orpha_code": "467",
    "disease_name": "Non-acquired combined pituitary hormone deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5258",
    "orpha_code": "142",
    "disease_name": "Anaplastic thyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5259",
    "orpha_code": "142",
    "disease_name": "Anaplastic thyroid carcinoma",
    "source": "European Medicines Agency 2004[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5255",
    "orpha_code": "143",
    "disease_name": "Parathyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5256",
    "orpha_code": "143",
    "disease_name": "Parathyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5257",
    "orpha_code": "143",
    "disease_name": "Parathyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5156",
    "orpha_code": "1461",
    "disease_name": "Criss-cross heart",
    "source": "ISBN:9781416023906[OTHER]_22555779[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10594",
    "orpha_code": "1461",
    "disease_name": "Criss-cross heart",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17525",
    "orpha_code": "499009",
    "disease_name": "Congenital syphilis",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13949",
    "orpha_code": "499009",
    "disease_name": "Congenital syphilis",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5152",
    "orpha_code": "1330",
    "disease_name": "Partial atrioventricular septal defect",
    "source": "23040494[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5153",
    "orpha_code": "1330",
    "disease_name": "Partial atrioventricular septal defect",
    "source": "[EXPERT]_17341403[PMID]_12084585[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5144",
    "orpha_code": "700",
    "disease_name": "Alopecia totalis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5216",
    "orpha_code": "315",
    "disease_name": "Erythrokeratoderma ''en cocardes''",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5214",
    "orpha_code": "122",
    "disease_name": "Birt-Hogg-Dub syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5178",
    "orpha_code": "658",
    "disease_name": "Non-histaminic angioedema",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5196",
    "orpha_code": "303",
    "disease_name": "Dystrophic epidermolysis bullosa",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5185",
    "orpha_code": "305",
    "disease_name": "Junctional epidermolysis bullosa",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10851",
    "orpha_code": "31837",
    "disease_name": "Pulmonary venoocclusive disease",
    "source": "16456139[PMID]_21510732[PMID]_ [EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "17158",
    "orpha_code": "31837",
    "disease_name": "Pulmonary venoocclusive disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5427",
    "orpha_code": "31824",
    "disease_name": "Colchicine poisoning",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10597",
    "orpha_code": "31043",
    "disease_name": "Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5415",
    "orpha_code": "31112",
    "disease_name": "Dermatofibrosarcoma protuberans",
    "source": "[EXPERT]_European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10596",
    "orpha_code": "30924",
    "disease_name": "Primary hypomagnesemia with secondary hypocalcemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10609",
    "orpha_code": "71212",
    "disease_name": "Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "16440",
    "orpha_code": "70591",
    "disease_name": "Chronic thromboembolic pulmonary hypertension",
    "source": "28356407[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6058",
    "orpha_code": "70589",
    "disease_name": "Bronchopulmonary dysplasia",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6054",
    "orpha_code": "70578",
    "disease_name": "Adult acute respiratory distress syndrome",
    "source": "European Medicines Agency 2008[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6046",
    "orpha_code": "70573",
    "disease_name": "Small cell lung cancer",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6045",
    "orpha_code": "70568",
    "disease_name": "Post-transplant lymphoproliferative disease",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6057",
    "orpha_code": "70588",
    "disease_name": "Meconium aspiration syndrome",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6043",
    "orpha_code": "70567",
    "disease_name": "Cholangiocarcinoma",
    "source": "emedicine 2011[OTHER]_22895392[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6044",
    "orpha_code": "70567",
    "disease_name": "Cholangiocarcinoma",
    "source": "European Medicines Agency 2004[INST]_22173164[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6022",
    "orpha_code": "70482",
    "disease_name": "Carcinoma of esophagus",
    "source": "World Health Organization 2008[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6023",
    "orpha_code": "70482",
    "disease_name": "Carcinoma of esophagus",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6024",
    "orpha_code": "70482",
    "disease_name": "Carcinoma of esophagus",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]_[EXPERT]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6020",
    "orpha_code": "70476",
    "disease_name": "Vernal keratoconjunctivitis",
    "source": "18356259[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6013",
    "orpha_code": "70475",
    "disease_name": "Radiation proctitis",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10608",
    "orpha_code": "69665",
    "disease_name": "Intrahepatic cholestasis of pregnancy",
    "source": "ORPHANET_22892336[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5986",
    "orpha_code": "69087",
    "disease_name": "Naegeli-Franceschetti-Jadassohn syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5974",
    "orpha_code": "69077",
    "disease_name": "Rhabdoid tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5976",
    "orpha_code": "69078",
    "disease_name": "Liposarcoma",
    "source": "22517534[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5969",
    "orpha_code": "69061",
    "disease_name": "Idiopathic steroid-sensitive nephrotic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5959",
    "orpha_code": "67043",
    "disease_name": "Amoebic keratitis",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5957",
    "orpha_code": "67041",
    "disease_name": "Hyaluronidase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5953",
    "orpha_code": "67038",
    "disease_name": "B-cell chronic lymphocytic leukemia",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12927",
    "orpha_code": "66627",
    "disease_name": "Tenosynovial giant cell tumor",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5897",
    "orpha_code": "64746",
    "disease_name": "Autosomal dominant Charcot-Marie-Tooth disease type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5898",
    "orpha_code": "64747",
    "disease_name": "X-linked Charcot-Marie-Tooth disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5899",
    "orpha_code": "64749",
    "disease_name": "Charcot-Marie-Tooth disease type 4",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5900",
    "orpha_code": "64752",
    "disease_name": "Hereditary sensory and autonomic neuropathy type 5",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11364",
    "orpha_code": "64280",
    "disease_name": "Childhood absence epilepsy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5892",
    "orpha_code": "64742",
    "disease_name": "Pleuropulmonary blastoma",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13650",
    "orpha_code": "64741",
    "disease_name": "Pulmonary blastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5864",
    "orpha_code": "63259",
    "disease_name": "Iniencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5875",
    "orpha_code": "63443",
    "disease_name": "Rare epithelial tumor of stomach",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5876",
    "orpha_code": "63443",
    "disease_name": "Rare epithelial tumor of stomach",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10737",
    "orpha_code": "63443",
    "disease_name": "Rare epithelial tumor of stomach",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5881",
    "orpha_code": "63446",
    "disease_name": "Acrocapitofemoral dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12985",
    "orpha_code": "60032",
    "disease_name": "Recurrent respiratory papillomatosis",
    "source": "ORPHANET_27208548[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "18075",
    "orpha_code": "60033",
    "disease_name": "Idiopathic bronchiectasis",
    "source": "9787927[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5853",
    "orpha_code": "60015",
    "disease_name": "Enlarged parietal foramina",
    "source": "23543411[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5825",
    "orpha_code": "57145",
    "disease_name": "SUNCT syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5823",
    "orpha_code": "56970",
    "disease_name": "Human prion disease",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5824",
    "orpha_code": "56970",
    "disease_name": "Human prion disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5822",
    "orpha_code": "56425",
    "disease_name": "Cold agglutinin disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5830",
    "orpha_code": "58017",
    "disease_name": "Classic hairy cell leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5831",
    "orpha_code": "58017",
    "disease_name": "Classic hairy cell leukemia",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5838",
    "orpha_code": "58017",
    "disease_name": "Classic hairy cell leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5798",
    "orpha_code": "54595",
    "disease_name": "Craniopharyngioma",
    "source": "17425791[PMID]_European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5796",
    "orpha_code": "54370",
    "disease_name": "Primary membranoproliferative glomerulonephritis",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5817",
    "orpha_code": "56044",
    "disease_name": "Carcinoma of gallbladder and extrahepatic biliary tract",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13619",
    "orpha_code": "56044",
    "disease_name": "Carcinoma of gallbladder and extrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5806",
    "orpha_code": "55880",
    "disease_name": "Chondrosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5807",
    "orpha_code": "55880",
    "disease_name": "Chondrosarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5808",
    "orpha_code": "55880",
    "disease_name": "Chondrosarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5809",
    "orpha_code": "55881",
    "disease_name": "Adamantinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11735",
    "orpha_code": "79213",
    "disease_name": "Mucopolysaccharidosis",
    "source": "ORPHANET_28595941[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15423",
    "orpha_code": "565782",
    "disease_name": "Methotrexate toxicity",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6314",
    "orpha_code": "79168",
    "disease_name": "Disorder of bile acid synthesis",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6257",
    "orpha_code": "79102",
    "disease_name": "Thyrotoxic periodic paralysis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6252",
    "orpha_code": "79098",
    "disease_name": "Sympathetic ophthalmia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11976",
    "orpha_code": "79096",
    "disease_name": "Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6286",
    "orpha_code": "79139",
    "disease_name": "Japanese encephalitis",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6289",
    "orpha_code": "79140",
    "disease_name": "Cutaneous neuroendocrine carcinoma",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6290",
    "orpha_code": "79140",
    "disease_name": "Cutaneous neuroendocrine carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6291",
    "orpha_code": "79140",
    "disease_name": "Cutaneous neuroendocrine carcinoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6269",
    "orpha_code": "79126",
    "disease_name": "Acute interstitial pneumonia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6208",
    "orpha_code": "77293",
    "disease_name": "Chronic visceral acid sphingomyelinase deficiency",
    "source": "23412609[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16802",
    "orpha_code": "77293",
    "disease_name": "Chronic visceral acid sphingomyelinase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6205",
    "orpha_code": "77261",
    "disease_name": "Gaucher disease type 3",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6206",
    "orpha_code": "77292",
    "disease_name": "Infantile neurovisceral acid sphingomyelinase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6207",
    "orpha_code": "77292",
    "disease_name": "Infantile neurovisceral acid sphingomyelinase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11990",
    "orpha_code": "79087",
    "disease_name": "Acquired partial lipodystrophy",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11972",
    "orpha_code": "79086",
    "disease_name": "Acquired generalized lipodystrophy",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6169",
    "orpha_code": "75377",
    "disease_name": "Central areolar choroidal dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6190",
    "orpha_code": "75564",
    "disease_name": "Acquired idiopathic sideroblastic anemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13713",
    "orpha_code": "75564",
    "disease_name": "Acquired idiopathic sideroblastic anemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6195",
    "orpha_code": "75840",
    "disease_name": "Ullrich congenital muscular dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6199",
    "orpha_code": "77240",
    "disease_name": "Primary lymphedema",
    "source": "[EXPERT]_24212289[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6204",
    "orpha_code": "77260",
    "disease_name": "Gaucher disease type 2",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6202",
    "orpha_code": "77259",
    "disease_name": "Gaucher disease type 1",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6156",
    "orpha_code": "75249",
    "disease_name": "Familial isolated restrictive cardiomyopathy",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6110",
    "orpha_code": "71529",
    "disease_name": "Obesity due to melanocortin 4 receptor deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6113",
    "orpha_code": "73217",
    "disease_name": "Mllerian aplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5591",
    "orpha_code": "39812",
    "disease_name": "Graft versus host disease",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5587",
    "orpha_code": "39044",
    "disease_name": "Uveal melanoma",
    "source": "17498805[PMID]_22119735[PMID]_EUROCARE Survival of cancer patients in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5588",
    "orpha_code": "39044",
    "disease_name": "Uveal melanoma",
    "source": "22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5589",
    "orpha_code": "39044",
    "disease_name": "Uveal melanoma",
    "source": "22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5578",
    "orpha_code": "37553",
    "disease_name": "Andersen-Tawil syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5577",
    "orpha_code": "37202",
    "disease_name": "Interstitial cystitis",
    "source": "ORPHANET_1137336[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5574",
    "orpha_code": "36899",
    "disease_name": "Myoclonus-dystonia syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5599",
    "orpha_code": "42062",
    "disease_name": "Iminoglycinuria",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5600",
    "orpha_code": "42062",
    "disease_name": "Iminoglycinuria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5520",
    "orpha_code": "35689",
    "disease_name": "Primary lateral sclerosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5512",
    "orpha_code": "35173",
    "disease_name": "X-linked dominant chondrodysplasia punctata",
    "source": "21634086[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10603",
    "orpha_code": "35173",
    "disease_name": "X-linked dominant chondrodysplasia punctata",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5509",
    "orpha_code": "35122",
    "disease_name": "Congenital sucrase-isomaltase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5508",
    "orpha_code": "35121",
    "disease_name": "Lysosomal acid phosphatase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5573",
    "orpha_code": "36426",
    "disease_name": "Stevens-Johnson syndrome",
    "source": "23866878[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10605",
    "orpha_code": "36426",
    "disease_name": "Stevens-Johnson syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11996",
    "orpha_code": "36258",
    "disease_name": "Buerger disease",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5538",
    "orpha_code": "35808",
    "disease_name": "Malignant sex cord stromal tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5539",
    "orpha_code": "35808",
    "disease_name": "Malignant sex cord stromal tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5534",
    "orpha_code": "35807",
    "disease_name": "Malignant germ cell tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5535",
    "orpha_code": "35807",
    "disease_name": "Malignant germ cell tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10604",
    "orpha_code": "35878",
    "disease_name": "Hyperinsulinism-hyperammonemia syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17514",
    "orpha_code": "35858",
    "disease_name": "Imerslund-Grsbeck syndrome",
    "source": "Pr Ralph GRSBECK[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5546",
    "orpha_code": "35909",
    "disease_name": "Combined deficiency of factor V and factor VIII",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5470",
    "orpha_code": "33543",
    "disease_name": "Kleine-Levin syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5466",
    "orpha_code": "33475",
    "disease_name": "Meningococcal meningitis",
    "source": "European Medicines Agency 2006[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10853",
    "orpha_code": "33402",
    "disease_name": "Pediatric hepatocellular carcinoma",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10599",
    "orpha_code": "33110",
    "disease_name": "Autosomal non-syndromic agammaglobulinemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5436",
    "orpha_code": "33069",
    "disease_name": "Dravet syndrome",
    "source": "22719002[PMID]_25772213[PMID]_ 31302675[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17159",
    "orpha_code": "33069",
    "disease_name": "Dravet syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5457",
    "orpha_code": "33355",
    "disease_name": "Reticular dysgenesis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5458",
    "orpha_code": "33355",
    "disease_name": "Reticular dysgenesis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12369",
    "orpha_code": "33364",
    "disease_name": "Trichothiodystrophy",
    "source": "18329345[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5453",
    "orpha_code": "33276",
    "disease_name": "Kaposi sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5454",
    "orpha_code": "33276",
    "disease_name": "Kaposi sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5455",
    "orpha_code": "33276",
    "disease_name": "Kaposi sarcoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11987",
    "orpha_code": "33208",
    "disease_name": "Idiopathic hypersomnia",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5446",
    "orpha_code": "33226",
    "disease_name": "Waldenstrm macroglobulinemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11438",
    "orpha_code": "33226",
    "disease_name": "Waldenstrm macroglobulinemia",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5491",
    "orpha_code": "34520",
    "disease_name": "Congenital muscular dystrophy with integrin alpha-7 deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5483",
    "orpha_code": "34515",
    "disease_name": "FKRP-related limb-girdle muscular dystrophy R9",
    "source": "19767415[PMID]_20961759[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11983",
    "orpha_code": "32960",
    "disease_name": "Tumor necrosis factor receptor 1 associated periodic syndrome",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5751",
    "orpha_code": "52688",
    "disease_name": "Myelodysplastic syndrome",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5752",
    "orpha_code": "52688",
    "disease_name": "Myelodysplastic syndrome",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5764",
    "orpha_code": "52688",
    "disease_name": "Myelodysplastic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5742",
    "orpha_code": "52416",
    "disease_name": "Mantle cell lymphoma",
    "source": "[EXPERT]_European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14488",
    "orpha_code": "52427",
    "disease_name": "Retinitis punctata albescens",
    "source": "ORPHANET_European Medecines Agency 2016[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5744",
    "orpha_code": "52417",
    "disease_name": "MALT lymphoma",
    "source": "[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5746",
    "orpha_code": "52417",
    "disease_name": "MALT lymphoma",
    "source": "European Medicines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5765",
    "orpha_code": "52759",
    "disease_name": "Vasculitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5775",
    "orpha_code": "53351",
    "disease_name": "X-linked dystonia-parkinsonism",
    "source": "15390042[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5782",
    "orpha_code": "53693",
    "disease_name": "GRACILE syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5688",
    "orpha_code": "49041",
    "disease_name": "IgG4-related retroperitoneal fibrosis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5690",
    "orpha_code": "49041",
    "disease_name": "IgG4-related retroperitoneal fibrosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5691",
    "orpha_code": "49042",
    "disease_name": "Dentinogenesis imperfecta",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5695",
    "orpha_code": "50251",
    "disease_name": "Pleural mesothelioma",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5696",
    "orpha_code": "50251",
    "disease_name": "Pleural mesothelioma",
    "source": "22406029[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5712",
    "orpha_code": "50839",
    "disease_name": "Cat-scratch disease",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5723",
    "orpha_code": "51577",
    "disease_name": "Cobblestone lissencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5621",
    "orpha_code": "43393",
    "disease_name": "Lambert-Eaton myasthenic syndrome",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5606",
    "orpha_code": "42738",
    "disease_name": "Severe congenital neutropenia",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5607",
    "orpha_code": "42738",
    "disease_name": "Severe congenital neutropenia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5633",
    "orpha_code": "45448",
    "disease_name": "Miyoshi myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5637",
    "orpha_code": "45453",
    "disease_name": "Incessant infant ventricular tachycardia",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5638",
    "orpha_code": "45453",
    "disease_name": "Incessant infant ventricular tachycardia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5634",
    "orpha_code": "45452",
    "disease_name": "Idiopathic neonatal atrial flutter",
    "source": "[EXPERT]_23551862[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5623",
    "orpha_code": "44890",
    "disease_name": "Gastrointestinal stromal tumor",
    "source": "European Medicines Agency[INST]_23623056[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5624",
    "orpha_code": "44890",
    "disease_name": "Gastrointestinal stromal tumor",
    "source": "21420965[PMID]_23623056[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12578",
    "orpha_code": "45358",
    "disease_name": "Congenital fibrosis of extraocular muscles",
    "source": "ORPHANET_9797671[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5651",
    "orpha_code": "46487",
    "disease_name": "Epidermolysis bullosa acquisita",
    "source": "7826096[PMID]_19170813[PMID]_7669112[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10607",
    "orpha_code": "46487",
    "disease_name": "Epidermolysis bullosa acquisita",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5648",
    "orpha_code": "46485",
    "disease_name": "Superficial pemphigus",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10606",
    "orpha_code": "46486",
    "disease_name": "Mucous membrane pemphigoid",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5646",
    "orpha_code": "46484",
    "disease_name": "Oligodendroglial tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5663",
    "orpha_code": "46724",
    "disease_name": "Cerebral arteriovenous malformation",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5671",
    "orpha_code": "48162",
    "disease_name": "Lewis-Sumner syndrome",
    "source": "19260065[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16410",
    "orpha_code": "544472",
    "disease_name": "Atypical hemolytic uremic syndrome with complement gene abnormality",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5664",
    "orpha_code": "47045",
    "disease_name": "Familial cold urticaria",
    "source": "24262697[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.5,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "5665",
    "orpha_code": "47045",
    "disease_name": "Familial cold urticaria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6997",
    "orpha_code": "90065",
    "disease_name": "Acquired aneurysmal subarachnoid hemorrhage",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6998",
    "orpha_code": "90066",
    "disease_name": "Pneumonia caused by Pseudomonas aeruginosa infection",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12916",
    "orpha_code": "90068",
    "disease_name": "Cocaine intoxication",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6994",
    "orpha_code": "90061",
    "disease_name": "Non-infectious posterior uveitis",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6995",
    "orpha_code": "90062",
    "disease_name": "Acute liver failure",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6996",
    "orpha_code": "90064",
    "disease_name": "Acute peripheral arterial occlusion",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12917",
    "orpha_code": "90073",
    "disease_name": "Hepatitis B reinfection following liver transplantation",
    "source": "European Medicines Agency 2004[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7000",
    "orpha_code": "90076",
    "disease_name": "Partial deep dermal and full thickness burns",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12918",
    "orpha_code": "90069",
    "disease_name": "Systemic monochloroacetate poisoning",
    "source": "European Medicines Agency 2004[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6984",
    "orpha_code": "90050",
    "disease_name": "Retinopathy of prematurity",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6986",
    "orpha_code": "90052",
    "disease_name": "Recurrent hepatitis C virus induced liver disease in liver transplant recipients",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6985",
    "orpha_code": "90051",
    "disease_name": "Sepsis in premature infants",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6991",
    "orpha_code": "90058",
    "disease_name": "Spinal cord injury",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6993",
    "orpha_code": "90060",
    "disease_name": "Diffuse alveolar hemorrhage",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6992",
    "orpha_code": "90059",
    "disease_name": "Sudden sensorineural hearing loss",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6987",
    "orpha_code": "90053",
    "disease_name": "Complications after hematopoietic stem cell transplantation",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6989",
    "orpha_code": "90056",
    "disease_name": "Moderate and severe traumatic brain injury",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6978",
    "orpha_code": "90037",
    "disease_name": "Drug-induced autoimmune hemolytic anemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10856",
    "orpha_code": "90038",
    "disease_name": "Shiga toxin-associated hemolytic uremic syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6976",
    "orpha_code": "90035",
    "disease_name": "Paroxysmal cold hemoglobinuria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6977",
    "orpha_code": "90036",
    "disease_name": "Mixed-type autoimmune hemolytic anemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6975",
    "orpha_code": "90033",
    "disease_name": "Autoimmune hemolytic anemia, warm type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12928",
    "orpha_code": "89936",
    "disease_name": "X-linked hypophosphatemia",
    "source": "PMID: 26543054 ; 31730177",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10623",
    "orpha_code": "89938",
    "disease_name": "Bartter syndrome type 4",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7030",
    "orpha_code": "90340",
    "disease_name": "Blau syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7009",
    "orpha_code": "90289",
    "disease_name": "Localized scleroderma",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7011",
    "orpha_code": "90291",
    "disease_name": "Systemic sclerosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7027",
    "orpha_code": "90308",
    "disease_name": "Capillary-lymphatic-venous malformation with segmental distribution",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7002",
    "orpha_code": "90080",
    "disease_name": "Scarring in glaucoma filtration surgical procedures",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7003",
    "orpha_code": "90081",
    "disease_name": "AIDS wasting syndrome",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6926",
    "orpha_code": "88673",
    "disease_name": "Hepatocellular carcinoma",
    "source": "European Medicines Agency 2017[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13614",
    "orpha_code": "88673",
    "disease_name": "Hepatocellular carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6906",
    "orpha_code": "88629",
    "disease_name": "Tritanopia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6895",
    "orpha_code": "87876",
    "disease_name": "Sialidosis type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10875",
    "orpha_code": "87876",
    "disease_name": "Sialidosis type 2",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13722",
    "orpha_code": "86900",
    "disease_name": "Interdigitating dendritic cell sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13723",
    "orpha_code": "86902",
    "disease_name": "Follicular dendritic cell sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13721",
    "orpha_code": "86896",
    "disease_name": "Histiocytic sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6945",
    "orpha_code": "88991",
    "disease_name": "Rare congenital non-syndromic heart malformation",
    "source": "21321151[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6942",
    "orpha_code": "88917",
    "disease_name": "X-linked Alport syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7134",
    "orpha_code": "93256",
    "disease_name": "Fragile X-associated tremor/ataxia syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10627",
    "orpha_code": "93108",
    "disease_name": "Renal dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10709",
    "orpha_code": "93108",
    "disease_name": "Renal dysplasia",
    "source": "EUROCAT European surveillance of congenital anomalies[REG]_21381187[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10828",
    "orpha_code": "93110",
    "disease_name": "Posterior urethral valve",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10929",
    "orpha_code": "93110",
    "disease_name": "Posterior urethral valve",
    "source": "[EXPERT]_19838598[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10626",
    "orpha_code": "93100",
    "disease_name": "Renal agenesis, unilateral",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7124",
    "orpha_code": "92050",
    "disease_name": "Congenital tufting enteropathy",
    "source": "Dr Julie Salomon_Dr Olivier Goulet[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10814",
    "orpha_code": "93111",
    "disease_name": "HNF1B-related autosomal dominant tubulointerstitial kidney disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10628",
    "orpha_code": "93172",
    "disease_name": "Renal dysplasia, unilateral",
    "source": "EUROCAT European surveillance of congenital anomalies[REG]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10710",
    "orpha_code": "93172",
    "disease_name": "Renal dysplasia, unilateral",
    "source": "EUROCAT European surveillance of congenital anomalies[REG]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10629",
    "orpha_code": "93173",
    "disease_name": "Renal dysplasia, bilateral",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7159",
    "orpha_code": "93322",
    "disease_name": "Isolated tibial hemimelia",
    "source": "16224672[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17162",
    "orpha_code": "93322",
    "disease_name": "Isolated tibial hemimelia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7157",
    "orpha_code": "93320",
    "disease_name": "Isolated ulnar hemimelia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10630",
    "orpha_code": "93337",
    "disease_name": "Polydactyly of an index finger",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7150",
    "orpha_code": "93314",
    "disease_name": "Spondylometaphyseal dysplasia, Kozlowski type",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7097",
    "orpha_code": "91378",
    "disease_name": "Hereditary angioedema",
    "source": "23662043[PMID]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7106",
    "orpha_code": "91397",
    "disease_name": "Isolated ankyloblepharon filiforme adnatum",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7117",
    "orpha_code": "91546",
    "disease_name": "Lyme disease",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": ">1 / 1000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5000.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10625",
    "orpha_code": "91546",
    "disease_name": "Lyme disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12911",
    "orpha_code": "91127",
    "disease_name": "Adenovirus infection in immunocompromised patients",
    "source": "European Medicines Agency 2003[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7063",
    "orpha_code": "90793",
    "disease_name": "Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7064",
    "orpha_code": "90794",
    "disease_name": "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7075",
    "orpha_code": "90795",
    "disease_name": "Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7076",
    "orpha_code": "90795",
    "disease_name": "Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7078",
    "orpha_code": "90970",
    "disease_name": "Primary lipodystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11271",
    "orpha_code": "91349",
    "disease_name": "Non-functioning pituitary adenoma",
    "source": "ORPHANET_25946030[PMID]_20534753[PMID]_10770176[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11272",
    "orpha_code": "91349",
    "disease_name": "Non-functioning pituitary adenoma",
    "source": "ORPHANET_26072284[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7091",
    "orpha_code": "91137",
    "disease_name": "Immunotactoid or fibrillary glomerulopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6503",
    "orpha_code": "79396",
    "disease_name": "Autosomal dominant generalized epidermolysis bullosa simplex, severe form",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6502",
    "orpha_code": "79394",
    "disease_name": "Congenital ichthyosiform erythroderma",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6506",
    "orpha_code": "79400",
    "disease_name": "Localized epidermolysis bullosa simplex",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6516",
    "orpha_code": "79404",
    "disease_name": "Severe generalized junctional epidermolysis bullosa",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6522",
    "orpha_code": "79408",
    "disease_name": "Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",
    "source": "31920360[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17520",
    "orpha_code": "79408",
    "disease_name": "Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",
    "source": "31920360[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10613",
    "orpha_code": "79445",
    "disease_name": "Pseudopseudohypoparathyroidism",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10612",
    "orpha_code": "79444",
    "disease_name": "Pseudohypoparathyroidism type 1C",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6549",
    "orpha_code": "79473",
    "disease_name": "Variegate porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6550",
    "orpha_code": "79473",
    "disease_name": "Variegate porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6368",
    "orpha_code": "79269",
    "disease_name": "Sanfilippo syndrome type A",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17519",
    "orpha_code": "79254",
    "disease_name": "Classic phenylketonuria",
    "source": "32024337[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17123",
    "orpha_code": "79254",
    "disease_name": "Classic phenylketonuria",
    "source": "32024337[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6359",
    "orpha_code": "79258",
    "disease_name": "Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6340",
    "orpha_code": "79241",
    "disease_name": "Biotinidase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6327",
    "orpha_code": "79239",
    "disease_name": "Classic galactosemia",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6347",
    "orpha_code": "79242",
    "disease_name": "Holocarboxylase synthetase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10611",
    "orpha_code": "79298",
    "disease_name": "Diazoxide-resistant focal hyperinsulinism",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6411",
    "orpha_code": "79278",
    "disease_name": "Autosomal erythropoietic protoporphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6412",
    "orpha_code": "79278",
    "disease_name": "Autosomal erythropoietic protoporphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6374",
    "orpha_code": "79270",
    "disease_name": "Sanfilippo syndrome type B",
    "source": "European Medicines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11973",
    "orpha_code": "79271",
    "disease_name": "Sanfilippo syndrome type C",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6385",
    "orpha_code": "79273",
    "disease_name": "Hereditary coproporphyria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6386",
    "orpha_code": "79276",
    "disease_name": "Acute intermittent porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6387",
    "orpha_code": "79276",
    "disease_name": "Acute intermittent porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6409",
    "orpha_code": "79277",
    "disease_name": "Congenital erythropoietic porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12356",
    "orpha_code": "79318",
    "disease_name": "PMM2-CDG",
    "source": "10854097[PMID]_11953730[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6455",
    "orpha_code": "79306",
    "disease_name": "Progressive familial intrahepatic cholestasis type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6453",
    "orpha_code": "79304",
    "disease_name": "Progressive familial intrahepatic cholestasis type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6454",
    "orpha_code": "79305",
    "disease_name": "Progressive familial intrahepatic cholestasis type 3",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6495",
    "orpha_code": "79361",
    "disease_name": "Inherited epidermolysis bullosa",
    "source": "20507631[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6496",
    "orpha_code": "79361",
    "disease_name": "Inherited epidermolysis bullosa",
    "source": "20507631[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6723",
    "orpha_code": "85197",
    "disease_name": "Genochondromatosis type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10619",
    "orpha_code": "85198",
    "disease_name": "Dysspondyloenchondromatosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6808",
    "orpha_code": "85332",
    "disease_name": "X-linked intellectual disability-retinitis pigmentosa syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6820",
    "orpha_code": "85410",
    "disease_name": "Oligoarticular juvenile idiopathic arthritis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6819",
    "orpha_code": "85408",
    "disease_name": "Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17168",
    "orpha_code": "85443",
    "disease_name": "AL amyloidosis",
    "source": "35854312[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17169",
    "orpha_code": "85443",
    "disease_name": "AL amyloidosis",
    "source": "35854312[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6830",
    "orpha_code": "85446",
    "disease_name": "Wild type ABeta2M amyloidosis",
    "source": "European Medicines Agency 2012[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6822",
    "orpha_code": "85435",
    "disease_name": "Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6824",
    "orpha_code": "85438",
    "disease_name": "Enthesitis-related juvenile idiopathic arthritis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6852",
    "orpha_code": "86812",
    "disease_name": "POMT1-related limb-girdle muscular dystrophy R11",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13683",
    "orpha_code": "86843",
    "disease_name": "Acute panmyelosis with myelofibrosis",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13716",
    "orpha_code": "86841",
    "disease_name": "Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13714",
    "orpha_code": "86839",
    "disease_name": "Myelodysplastic neoplasm with increased blasts",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13715",
    "orpha_code": "86836",
    "disease_name": "Refractory cytopenia with multilineage dysplasia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6870",
    "orpha_code": "86834",
    "disease_name": "Juvenile myelomonocytic leukemia",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13710",
    "orpha_code": "86830",
    "disease_name": "Chronic myeloproliferative disease, unclassifiable",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13711",
    "orpha_code": "86829",
    "disease_name": "Chronic neutrophilic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14482",
    "orpha_code": "86854",
    "disease_name": "Splenic marginal zone lymphoma",
    "source": "European Medecines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13696",
    "orpha_code": "86852",
    "disease_name": "B-cell prolymphocytic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13685",
    "orpha_code": "86850",
    "disease_name": "Myeloid sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13681",
    "orpha_code": "86849",
    "disease_name": "Acute basophilic leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13706",
    "orpha_code": "86846",
    "disease_name": "Therapy related acute myeloid leukemia and myelodysplastic syndrome",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13684",
    "orpha_code": "86845",
    "disease_name": "Acute myeloid leukaemia with myelodysplasia-related features",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6875",
    "orpha_code": "86872",
    "disease_name": "T-cell large granular lymphocyte leukemia",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10621",
    "orpha_code": "86873",
    "disease_name": "Aggressive NK-cell leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11975",
    "orpha_code": "86870",
    "disease_name": "Blastic plasmacytoid dendritic cell neoplasm",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14483",
    "orpha_code": "86867",
    "disease_name": "Nodal marginal zone B-cell lymphoma",
    "source": "European Medecines Agency 2013[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13700",
    "orpha_code": "86864",
    "disease_name": "Heavy chain disease",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6882",
    "orpha_code": "86893",
    "disease_name": "Nodular lymphocyte predominant Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "12919",
    "orpha_code": "86875",
    "disease_name": "Adult T-cell leukemia/lymphoma",
    "source": "European Medicines Agency 2014[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10614",
    "orpha_code": "79644",
    "disease_name": "Autosomal recessive hyperinsulinism due to Kir6.2 deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6595",
    "orpha_code": "83330",
    "disease_name": "Proximal spinal muscular atrophy type 1",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10615",
    "orpha_code": "83330",
    "disease_name": "Proximal spinal muscular atrophy type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10617",
    "orpha_code": "83419",
    "disease_name": "Proximal spinal muscular atrophy type 3",
    "source": "28676062[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6598",
    "orpha_code": "83420",
    "disease_name": "Proximal spinal muscular atrophy type 4",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10618",
    "orpha_code": "83420",
    "disease_name": "Proximal spinal muscular atrophy type 4",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "6596",
    "orpha_code": "83418",
    "disease_name": "Proximal spinal muscular atrophy type 2",
    "source": "10677857[PMID]_1483045[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6588",
    "orpha_code": "83313",
    "disease_name": "Boutonneuse fever",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6629",
    "orpha_code": "83469",
    "disease_name": "Desmoplastic small round cell tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11966",
    "orpha_code": "83476",
    "disease_name": "West-Nile encephalitis",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6610",
    "orpha_code": "83463",
    "disease_name": "Microtia",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6611",
    "orpha_code": "83463",
    "disease_name": "Microtia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6608",
    "orpha_code": "83461",
    "disease_name": "Congenital primary aphakia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6651",
    "orpha_code": "83601",
    "disease_name": "Steroid-responsive encephalopathy associated with autoimmune thyroiditis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6648",
    "orpha_code": "83597",
    "disease_name": "Acute disseminated encephalomyelitis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6650",
    "orpha_code": "83600",
    "disease_name": "Encephalitis lethargica",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6641",
    "orpha_code": "83484",
    "disease_name": "St. Louis encephalitis",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6644",
    "orpha_code": "83593",
    "disease_name": "Western equine encephalitis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6687",
    "orpha_code": "85138",
    "disease_name": "Addison disease",
    "source": "21164269[PMID]_12788587[PMID]_ [EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6714",
    "orpha_code": "85179",
    "disease_name": "Infantile osteopetrosis with neuroaxonal dysplasia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7438",
    "orpha_code": "98249",
    "disease_name": "Ehlers-Danlos syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2005-2012[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13720",
    "orpha_code": "98287",
    "disease_name": "Histiocytic and dendritic cell tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7441",
    "orpha_code": "98293",
    "disease_name": "Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7442",
    "orpha_code": "98293",
    "disease_name": "Hodgkin lymphoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7440",
    "orpha_code": "98292",
    "disease_name": "Mastocytosis",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13708",
    "orpha_code": "98274",
    "disease_name": "Myeloproliferative neoplasm",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13701",
    "orpha_code": "98277",
    "disease_name": "Acute myeloid leukemia with recurrent genetic anomaly",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13717",
    "orpha_code": "98275",
    "disease_name": "Myelodysplastic/myeloproliferative disease",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7396",
    "orpha_code": "97242",
    "disease_name": "Congenital muscular dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10903",
    "orpha_code": "97253",
    "disease_name": "Neuroendocrine tumor of pancreas",
    "source": "15016750[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10917",
    "orpha_code": "97253",
    "disease_name": "Neuroendocrine tumor of pancreas",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10906",
    "orpha_code": "97279",
    "disease_name": "Insulinoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10911",
    "orpha_code": "97283",
    "disease_name": "Somatostatinoma",
    "source": "[EXPERT]_17645474[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10912",
    "orpha_code": "97283",
    "disease_name": "Somatostatinoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10909",
    "orpha_code": "97282",
    "disease_name": "VIPoma",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10910",
    "orpha_code": "97282",
    "disease_name": "VIPoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10907",
    "orpha_code": "97280",
    "disease_name": "Glucagonoma",
    "source": "9113318[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10908",
    "orpha_code": "97280",
    "disease_name": "Glucagonoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7410",
    "orpha_code": "97292",
    "disease_name": "Cardiogenic shock",
    "source": "European Medicines Agency 2008[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7425",
    "orpha_code": "97363",
    "disease_name": "Unilateral multicystic dysplastic kidney",
    "source": "16053904[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10642",
    "orpha_code": "97363",
    "disease_name": "Unilateral multicystic dysplastic kidney",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "16726",
    "orpha_code": "97560",
    "disease_name": "Primary membranous glomerulonephritis",
    "source": "21068142[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7375",
    "orpha_code": "96253",
    "disease_name": "Cushing disease",
    "source": "European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7376",
    "orpha_code": "96253",
    "disease_name": "Cushing disease",
    "source": "22710101[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7379",
    "orpha_code": "96264",
    "disease_name": "49,XXXXY syndrome",
    "source": "7567329[PMID]_[EXPERT]_ ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7377",
    "orpha_code": "96263",
    "disease_name": "48,XXXY syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7378",
    "orpha_code": "96263",
    "disease_name": "48,XXXY syndrome",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7382",
    "orpha_code": "97214",
    "disease_name": "Eisenmenger syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10801",
    "orpha_code": "97593",
    "disease_name": "Pseudohypoparathyroidism",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14711",
    "orpha_code": "95706",
    "disease_name": "Non-syndromic posterior hypospadias",
    "source": "25712311[PMID]_26810252[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14712",
    "orpha_code": "95706",
    "disease_name": "Non-syndromic posterior hypospadias",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7353",
    "orpha_code": "95715",
    "disease_name": "Congenital hypothyroidism due to transplacental passage of TSH-binding inhibitory antibodies",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7355",
    "orpha_code": "95716",
    "disease_name": "Familial thyroid dyshormonogenesis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7351",
    "orpha_code": "95713",
    "disease_name": "Athyreosis",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7349",
    "orpha_code": "95711",
    "disease_name": "Congenital hypothyroidism due to developmental anomaly",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7350",
    "orpha_code": "95712",
    "disease_name": "Thyroid ectopia",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7347",
    "orpha_code": "95699",
    "disease_name": "Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7319",
    "orpha_code": "95157",
    "disease_name": "Acute hepatic porphyria",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10641",
    "orpha_code": "95430",
    "disease_name": "Congenital tracheomalacia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7327",
    "orpha_code": "95429",
    "disease_name": "Angioma serpiginosum",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7304",
    "orpha_code": "94068",
    "disease_name": "Spondyloepiphyseal dysplasia congenita",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10640",
    "orpha_code": "94090",
    "disease_name": "Pseudohypoparathyroidism type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10639",
    "orpha_code": "94089",
    "disease_name": "Pseudohypoparathyroidism type 1B",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "12443",
    "orpha_code": "93476",
    "disease_name": "Hurler-Scheie syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10764",
    "orpha_code": "93473",
    "disease_name": "Hurler syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10772",
    "orpha_code": "93473",
    "disease_name": "Hurler syndrome",
    "source": "ORPHANET_16435194[PMID]_14685153[PMID]_18681890[PMID]_18796143[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7188",
    "orpha_code": "93402",
    "disease_name": "Syndactyly type 1",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7189",
    "orpha_code": "93402",
    "disease_name": "Syndactyly type 1",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17103",
    "orpha_code": "599480",
    "disease_name": "Acquired hemophilia A",
    "source": "36331704[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17104",
    "orpha_code": "599480",
    "disease_name": "Acquired hemophilia A",
    "source": "14675412[PMID]_17047148 [PMID]_32937680 [PMID]_36331704 [PMID]_37021783[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12447",
    "orpha_code": "93360",
    "disease_name": "Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7174",
    "orpha_code": "93383",
    "disease_name": "Brachydactyly type B",
    "source": "ORPHANET_18554391[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7185",
    "orpha_code": "93396",
    "disease_name": "Brachydactyly type A2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7291",
    "orpha_code": "94059",
    "disease_name": "Uremic pruritus",
    "source": "European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7290",
    "orpha_code": "94058",
    "disease_name": "Neovascular glaucoma",
    "source": "European Medicines Agency 2003[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7274",
    "orpha_code": "93976",
    "disease_name": "Anotia",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.8,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7275",
    "orpha_code": "93976",
    "disease_name": "Anotia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7236",
    "orpha_code": "93930",
    "disease_name": "Classic bladder exstrophy",
    "source": "ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 3.8,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7237",
    "orpha_code": "93930",
    "disease_name": "Classic bladder exstrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7228",
    "orpha_code": "93928",
    "disease_name": "Isolated epispadias",
    "source": "19878548[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7229",
    "orpha_code": "93928",
    "disease_name": "Isolated epispadias",
    "source": "19878548[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7230",
    "orpha_code": "93929",
    "disease_name": "Cloacal exstrophy",
    "source": "19878548[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7231",
    "orpha_code": "93929",
    "disease_name": "Cloacal exstrophy",
    "source": "19878548[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7225",
    "orpha_code": "93924",
    "disease_name": "Lobar holoprosencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7226",
    "orpha_code": "93925",
    "disease_name": "Alobar holoprosencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10638",
    "orpha_code": "93672",
    "disease_name": "Juvenile dermatomyositis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "16412",
    "orpha_code": "93591",
    "disease_name": "Infantile nephronophthisis",
    "source": "European Rare Kidney Diseases Reference Network[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10881",
    "orpha_code": "93585",
    "disease_name": "Immune-mediated thrombotic thrombocytopenic purpura",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10637",
    "orpha_code": "93610",
    "disease_name": "Distal renal tubular acidosis with anemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10636",
    "orpha_code": "93608",
    "disease_name": "Autosomal dominant distal renal tubular acidosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10635",
    "orpha_code": "93607",
    "disease_name": "Autosomal recessive proximal renal tubular acidosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10632",
    "orpha_code": "93600",
    "disease_name": "Primary hyperoxaluria type 3",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10631",
    "orpha_code": "93599",
    "disease_name": "Primary hyperoxaluria type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10634",
    "orpha_code": "93605",
    "disease_name": "Bartter syndrome type 3",
    "source": "ORPHANET_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10649",
    "orpha_code": "99094",
    "disease_name": "Laubry-Pezzi syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "10650",
    "orpha_code": "99095",
    "disease_name": "Congenital Gerbode defect",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7781",
    "orpha_code": "99429",
    "disease_name": "Complete androgen insensitivity syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7784",
    "orpha_code": "99718",
    "disease_name": "Leber plus disease",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7802",
    "orpha_code": "99750",
    "disease_name": "Atypical progressive supranuclear palsy syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7787",
    "orpha_code": "99736",
    "disease_name": "Acetazolamide-responsive myotonia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7791",
    "orpha_code": "99745",
    "disease_name": "Typhoid",
    "source": "15298225[PMID]_[EXPERT]_World Health Organization[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7562",
    "orpha_code": "98813",
    "disease_name": "Hypohidrotic ectodermal dysplasia with immunodeficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7557",
    "orpha_code": "98808",
    "disease_name": "Autosomal dominant dopa-responsive dystonia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11988",
    "orpha_code": "98838",
    "disease_name": "Primary mediastinal large B-cell lymphoma",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13678",
    "orpha_code": "98833",
    "disease_name": "Acute myeloblastic leukemia without maturation",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13679",
    "orpha_code": "98834",
    "disease_name": "Acute myeloblastic leukemia with maturation",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13704",
    "orpha_code": "98831",
    "disease_name": "Acute myeloid leukemia with 11q23 abnormalities",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13677",
    "orpha_code": "98832",
    "disease_name": "Acute myeloid leukemia with minimal differentiation",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13703",
    "orpha_code": "98829",
    "disease_name": "Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13719",
    "orpha_code": "98824",
    "disease_name": "Atypical chronic myeloid leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7569",
    "orpha_code": "98851",
    "disease_name": "Mast cell leukemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13709",
    "orpha_code": "98851",
    "disease_name": "Mast cell leukemia",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7566",
    "orpha_code": "98848",
    "disease_name": "Indolent systemic mastocytosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7568",
    "orpha_code": "98850",
    "disease_name": "Aggressive systemic mastocytosis",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7567",
    "orpha_code": "98849",
    "disease_name": "Systemic mastocytosis with associated hematologic neoplasm",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13675",
    "orpha_code": "98844",
    "disease_name": "Classic Hodgkin lymphoma, mixed cellularity type",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13692",
    "orpha_code": "98843",
    "disease_name": "Classic Hodgkin lymphoma, nodular sclerosis type",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13676",
    "orpha_code": "98846",
    "disease_name": "Classic Hodgkin lymphoma, lymphocyte-depleted type",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13674",
    "orpha_code": "98845",
    "disease_name": "Classic Hodgkin lymphoma, lymphocyte-rich type",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10644",
    "orpha_code": "98842",
    "disease_name": "Lymphomatoid papulosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7565",
    "orpha_code": "98841",
    "disease_name": "Anaplastic large cell lymphoma",
    "source": "European Medicines Agency 2011[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10645",
    "orpha_code": "98868",
    "disease_name": "Southeast Asian ovalocytosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7574",
    "orpha_code": "98869",
    "disease_name": "Congenital dyserythropoietic anemia type I",
    "source": "20665989[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7689",
    "orpha_code": "98879",
    "disease_name": "Hemophilia B",
    "source": "21649801[PMID]_European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7578",
    "orpha_code": "98873",
    "disease_name": "Congenital dyserythropoietic anemia type II",
    "source": "20665989[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "18089",
    "orpha_code": "98873",
    "disease_name": "Congenital dyserythropoietic anemia type II",
    "source": "20665989[PMID]",
    "prevalence_type": "Cases/families",
    "prevalence_class": null,
    "qualification": "Case(s)",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7583",
    "orpha_code": "98878",
    "disease_name": "Hemophilia A",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7702",
    "orpha_code": "98895",
    "disease_name": "Becker muscular dystrophy",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7707",
    "orpha_code": "98895",
    "disease_name": "Becker muscular dystrophy",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7716",
    "orpha_code": "98902",
    "disease_name": "Amish nemaline myopathy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7720",
    "orpha_code": "98916",
    "disease_name": "Acute inflammatory demyelinating polyradiculoneuropathy",
    "source": "[EXPERT]_European Medicines Agency[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7717",
    "orpha_code": "98907",
    "disease_name": "Neutral lipid storage disease with ichthyosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7723",
    "orpha_code": "98933",
    "disease_name": "Multiple system atrophy, parkinsonian type",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 5.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7721",
    "orpha_code": "98919",
    "disease_name": "Miller Fisher syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7722",
    "orpha_code": "98919",
    "disease_name": "Miller Fisher syndrome",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7732",
    "orpha_code": "98957",
    "disease_name": "Gelatinous drop-like corneal dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7745",
    "orpha_code": "98969",
    "disease_name": "Macular corneal dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7757",
    "orpha_code": "98976",
    "disease_name": "Congenital glaucoma",
    "source": "EUROCAT European surveillance of congenital anomalies 2000-2016[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10647",
    "orpha_code": "98976",
    "disease_name": "Congenital glaucoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10648",
    "orpha_code": "99000",
    "disease_name": "Adult-onset foveomacular vitelliform dystrophy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7456",
    "orpha_code": "98555",
    "disease_name": "Microphthalmia-anophthalmia-coloboma",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7457",
    "orpha_code": "98555",
    "disease_name": "Microphthalmia-anophthalmia-coloboma",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16542",
    "orpha_code": "583861",
    "disease_name": "Isolated mesenteric vein thrombosis",
    "source": "18720461[PMID]_25917534[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17526",
    "orpha_code": "583861",
    "disease_name": "Isolated mesenteric vein thrombosis",
    "source": "18720461[PMID]_25917534[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7504",
    "orpha_code": "98715",
    "disease_name": "Uveitis",
    "source": "8407119[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7505",
    "orpha_code": "98715",
    "disease_name": "Uveitis",
    "source": "8407119[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7506",
    "orpha_code": "98723",
    "disease_name": "Hypoplastic right heart syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10643",
    "orpha_code": "98784",
    "disease_name": "Sleep-related hypermotor epilepsy",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "11994",
    "orpha_code": "98306",
    "disease_name": "Familial partial lipodystrophy",
    "source": "European Medicines Agency 2016[INST]_29066925[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7447",
    "orpha_code": "98375",
    "disease_name": "Autoimmune hemolytic anemia",
    "source": "[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7450",
    "orpha_code": "98375",
    "disease_name": "Autoimmune hemolytic anemia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16385",
    "orpha_code": "570762",
    "disease_name": "Infective endocarditis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "16388",
    "orpha_code": "570762",
    "disease_name": "Infective endocarditis",
    "source": "ORPHANET_25432123[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16336",
    "orpha_code": "570470",
    "disease_name": "Ricin poisoning",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13602",
    "orpha_code": "104075",
    "disease_name": "Adenocarcinoma of the small intestine",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8052",
    "orpha_code": "104008",
    "disease_name": "Short bowel syndrome",
    "source": "European Medicines Agency 2019[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13702",
    "orpha_code": "102724",
    "disease_name": "Acute myeloid leukemia with t(8;21)(q22;q22) translocation",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "8027",
    "orpha_code": "101997",
    "disease_name": "Primary immunodeficiency",
    "source": "22288591[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8025",
    "orpha_code": "101959",
    "disease_name": "Chronic primary adrenal insufficiency",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8026",
    "orpha_code": "101959",
    "disease_name": "Chronic primary adrenal insufficiency",
    "source": "12788587[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8020",
    "orpha_code": "101150",
    "disease_name": "Autosomal recessive dopa-responsive dystonia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8021",
    "orpha_code": "101330",
    "disease_name": "Porphyria cutanea tarda",
    "source": "19233912[PMID]_9516680[PMID]_[EXPERT]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8022",
    "orpha_code": "101330",
    "disease_name": "Porphyria cutanea tarda",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8005",
    "orpha_code": "101083",
    "disease_name": "Charcot-Marie-Tooth disease type 1C",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7993",
    "orpha_code": "101016",
    "disease_name": "Romano-Ward syndrome",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10839",
    "orpha_code": "100984",
    "disease_name": "Autosomal dominant spastic paraplegia type 3",
    "source": "20862796[PMID]_8649538[PMID]_23609960[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7950",
    "orpha_code": "100980",
    "disease_name": "Autosomal dominant pure spastic paraplegia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7947",
    "orpha_code": "100979",
    "disease_name": "Autosomal dominant complex spastic paraplegia",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7953",
    "orpha_code": "100986",
    "disease_name": "Autosomal recessive spastic paraplegia type 5A",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7935",
    "orpha_code": "100088",
    "disease_name": "Rare thyroid carcinoma",
    "source": "22033323[PMID]_23894154[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7936",
    "orpha_code": "100088",
    "disease_name": "Rare thyroid carcinoma",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7932",
    "orpha_code": "100087",
    "disease_name": "Rare thyroid tumor",
    "source": "21513910[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7941",
    "orpha_code": "100924",
    "disease_name": "Porphyria due to ALA dehydratase deficiency",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7942",
    "orpha_code": "100973",
    "disease_name": "FRAXE intellectual disability",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7928",
    "orpha_code": "100070",
    "disease_name": "Progressive non-fluent aphasia",
    "source": "22608668[PMID]_European Medicines Agency 2010[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7929",
    "orpha_code": "100070",
    "disease_name": "Progressive non-fluent aphasia",
    "source": "22608668[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10962",
    "orpha_code": "100075",
    "disease_name": "Neuroendocrine tumor of stomach",
    "source": "25480460[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10914",
    "orpha_code": "100050",
    "disease_name": "Hereditary angioedema type 1",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10654",
    "orpha_code": "99994",
    "disease_name": "Complex regional pain syndrome type 2",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7907",
    "orpha_code": "99981",
    "disease_name": "Apnea of prematurity",
    "source": "European Medicines Agency 2003[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7906",
    "orpha_code": "99978",
    "disease_name": "Perihilar cholangiocarcinoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7902",
    "orpha_code": "99977",
    "disease_name": "Squamous cell carcinoma of the esophagus",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7903",
    "orpha_code": "99977",
    "disease_name": "Squamous cell carcinoma of the esophagus",
    "source": "22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7904",
    "orpha_code": "99977",
    "disease_name": "Squamous cell carcinoma of the esophagus",
    "source": "22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7899",
    "orpha_code": "99976",
    "disease_name": "Adenocarcinoma of the oesophagus and oesophagogastric junction",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7900",
    "orpha_code": "99976",
    "disease_name": "Adenocarcinoma of the oesophagus and oesophagogastric junction",
    "source": "22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7901",
    "orpha_code": "99976",
    "disease_name": "Adenocarcinoma of the oesophagus and oesophagogastric junction",
    "source": "22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7897",
    "orpha_code": "99971",
    "disease_name": "Well-differentiated liposarcoma",
    "source": "22517534[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7893",
    "orpha_code": "99969",
    "disease_name": "Pleomorphic liposarcoma",
    "source": "22517534[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7895",
    "orpha_code": "99970",
    "disease_name": "Dedifferentiated liposarcoma",
    "source": "22517534[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7891",
    "orpha_code": "99967",
    "disease_name": "Myxoid/round cell liposarcoma",
    "source": "22517534[PMID]_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7882",
    "orpha_code": "99952",
    "disease_name": "Charcot-Marie-Tooth disease type 4F",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7869",
    "orpha_code": "99931",
    "disease_name": "Idiopathic pulmonary hemosiderosis",
    "source": "[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10653",
    "orpha_code": "99931",
    "disease_name": "Idiopathic pulmonary hemosiderosis",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7866",
    "orpha_code": "99928",
    "disease_name": "Placental site trophoblastic tumor",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7867",
    "orpha_code": "99928",
    "disease_name": "Placental site trophoblastic tumor",
    "source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7868",
    "orpha_code": "99928",
    "disease_name": "Placental site trophoblastic tumor",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13639",
    "orpha_code": "99917",
    "disease_name": "Theca steroid-producing cell malignant tumor of ovary, not further specified",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13638",
    "orpha_code": "99916",
    "disease_name": "Malignant Sertoli-Leydig cell tumor of the ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "13637",
    "orpha_code": "99915",
    "disease_name": "Malignant granulosa cell tumor of the ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13641",
    "orpha_code": "99912",
    "disease_name": "Ovarian dysgerminoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7845",
    "orpha_code": "99885",
    "disease_name": "Isolated permanent neonatal diabetes mellitus",
    "source": "19499210[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7846",
    "orpha_code": "99885",
    "disease_name": "Isolated permanent neonatal diabetes mellitus",
    "source": "19499210[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10808",
    "orpha_code": "99886",
    "disease_name": "Transient neonatal diabetes mellitus",
    "source": "[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10809",
    "orpha_code": "99886",
    "disease_name": "Transient neonatal diabetes mellitus",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7834",
    "orpha_code": "99865",
    "disease_name": "Spermatocytic seminoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "10652",
    "orpha_code": "99865",
    "disease_name": "Spermatocytic seminoma",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "7835",
    "orpha_code": "99867",
    "disease_name": "Thymoma",
    "source": "[EXPERT]_RARECARE surveillance of rare cancers in Europe 2011[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7836",
    "orpha_code": "99867",
    "disease_name": "Thymoma",
    "source": "22033323[PMID]_[EXPERT]_RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Lifetime Prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11968",
    "orpha_code": "99829",
    "disease_name": "Yellow fever",
    "source": "European Centre for Disease prevention and Control 2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "11950",
    "orpha_code": "99828",
    "disease_name": "Dengue fever",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12660",
    "orpha_code": "99828",
    "disease_name": "Dengue fever",
    "source": "European Medicines Agency 2015[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14798",
    "orpha_code": "99827",
    "disease_name": "Crimean-Congo hemorrhagic fever",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7826",
    "orpha_code": "99842",
    "disease_name": "Leukocyte adhesion deficiency type I",
    "source": "[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17884",
    "orpha_code": "650077",
    "disease_name": "Genetic central precocious puberty in female",
    "source": "38857188[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14797",
    "orpha_code": "99824",
    "disease_name": "Lassa fever",
    "source": "European Medicines Agency 2018[INST]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7813",
    "orpha_code": "99810",
    "disease_name": "Familial porencephaly",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "7805",
    "orpha_code": "99789",
    "disease_name": "Dentin dysplasia type I",
    "source": "17452557[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7804",
    "orpha_code": "99772",
    "disease_name": "Cleft velum",
    "source": "ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Not yet validated",
    "reliability_score": 4.0,
    "is_fiable": false,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17695",
    "orpha_code": "636945",
    "disease_name": "Invasive candidiasis",
    "source": "27394927[PMID]_32809459[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17693",
    "orpha_code": "636955",
    "disease_name": "Endemic pemphigus foliaceus",
    "source": "34909708[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17692",
    "orpha_code": "636950",
    "disease_name": "Glaucomatocyclitic crisis disease",
    "source": "35015437[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17713",
    "orpha_code": "641496",
    "disease_name": "Childhood-onset schizophrenia",
    "source": "22906158[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17714",
    "orpha_code": "641496",
    "disease_name": "Childhood-onset schizophrenia",
    "source": "22906158[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17711",
    "orpha_code": "641350",
    "disease_name": "Immunotherapy induced hypophysitis",
    "source": "28702249[PMID]_34430146[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17712",
    "orpha_code": "641350",
    "disease_name": "Immunotherapy induced hypophysitis",
    "source": "28702249[PMID]_34430146[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "Unknown",
    "qualification": "Class only",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 0.0,
    "confidence_level": "none",
    "estimate_source": "no_data"
  },
  {
    "prevalence_id": "17675",
    "orpha_code": "633124",
    "disease_name": "Invasive scopulariopsis infection",
    "source": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2563",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "17631",
    "orpha_code": "623615",
    "disease_name": "Autoimmune limbic encephalitis",
    "source": "31552550[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17632",
    "orpha_code": "623615",
    "disease_name": "Autoimmune limbic encephalitis",
    "source": "31552550[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17633",
    "orpha_code": "623626",
    "disease_name": "Paraneoplastic cerebellar degeneration",
    "source": "31552550[PMID]_32847939[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17634",
    "orpha_code": "623626",
    "disease_name": "Paraneoplastic cerebellar degeneration",
    "source": "31552550[PMID]_32847939[PMID]_ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Europe",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  }
]